{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:51:33Z","timestamp":1791640293811,"version":"4.3.4"},"reference-count":361,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2021,1,27]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Epilepsy is the second most common neurological disease with abnormal neural activity\ninvolving the activation of various intracellular signalling transduction mechanisms. The molecular\nand system biology mechanisms responsible for epileptogenesis are not well defined or understood.\nNeuroinflammation, neurodegeneration and Epigenetic modification elicit epileptogenesis.\nThe excessive neuronal activities in the brain are associated with neurochemical changes underlying\nthe deleterious consequences of excitotoxicity. The prolonged repetitive excessive neuronal activities\nextended to brain tissue injury by the activation of microglia regulating abnormal neuroglia\nremodelling and monocyte infiltration in response to brain lesions inducing axonal sprouting contributing\nto neurodegeneration. The alteration of various downstream transduction pathways resulted\nin intracellular stress responses associating endoplasmic reticulum, mitochondrial and lysosomal\ndysfunction, activation of nucleases, proteases mediated neuronal death. The recently novel\npharmacological agents modulate various receptors like mTOR, COX-2, TRK, JAK-STAT, epigenetic\nmodulators and neurosteroids are used for attenuation of epileptogenesis. Whereas the various\nmolecular changes like the mutation of the cell surface, nuclear receptor and ion channels focusing\non repetitive episodic seizures have been explored by preclinical and clinical studies. Despite\neffective pharmacotherapy for epilepsy, the inadequate understanding of precise mechanisms,\ndrug resistance and therapeutic failure are the current fundamental problems in epilepsy. Therefore,\nthe novel pharmacological approaches evaluated for efficacy on experimental models of epilepsy\nneed to be identified and validated. In addition, we need to understand the downstream signalling\npathways of new targets for the treatment of epilepsy. This review emphasizes on the current state\nof novel molecular targets as therapeutic approaches and future directions for the management of\nepileptogenesis. Novel pharmacological approaches and clinical exploration are essential to make\nnew frontiers in curing epilepsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1871527319666200910153827","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T07:52:36Z","timestamp":1599810756000},"page":"750-779","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis"],"prefix":"10.2174","volume":"19","author":[{"given":"Shareen","family":"Singh","sequence":"first","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":true,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Kumar","family":"Rehni","sequence":"additional","affiliation":[{"name":"Cerebral Vascular Disease Research Laboratories, Department of Neurology and Neuroscience Program, University of Miami School of Medicine, Miami, Florida 33101, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1254\/fpj.152.275","volume":"152","author":"Tokudome K.","year":"2018","unstructured":"Tokudome K.; Shimizu S.; Serikawa T.; Ohno Y.; Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy. Nihon yakurigaku zasshi Folia pharmacologica Japonica 2018,152,275-80","journal-title":"Nihon yakurigaku zasshi Folia pharmacologica Japonica"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e58180","DOI":"10.1371\/journal.pone.0058180","volume":"8","author":"Chipaux M.","year":"2013","unstructured":"Chipaux M.; Vercueil L.; Kaminska A.; Mahon S.; Charpier S.; Persistence of cortical sensory processing during absence seizures in human and an animal model: evidence from EEG and intracellular recordings. PLoS One 2013,8(3),e58180","journal-title":"PLoS One"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1684\/epd.2017.0952","volume":"19","author":"Koutroumanidis M.","year":"2017","unstructured":"Koutroumanidis M.; Arzimanoglou A.; Caraballo R.; Goyal S.; Kaminska A.; Laoprasert P.; Oguni H.; Rubboli G.; Tatum W.; Thomas P.; Trinka E.; Vignatelli L.; Mosh\u00e9 S.L.; The role of EEG in the diagnosis and classification of the epilepsy syndromes: a tool for clinical practice by the ILAE Neurophysiology Task Force (Part 2). Epileptic Disord 2017,19(4),385-437","journal-title":"Epileptic Disord"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.yebeh.2017.03.029","volume":"70","author":"De Marchi L.R.","year":"2017","unstructured":"De Marchi L.R.; Corso J.T.; Zetehaku A.C.; Uchida C.G.P.; Guaranha M.S.B.; Yacubian E.M.T.; Efficacy and safety of a video-EEG protocol for genetic generalized epilepsies. Epilepsy Behav 2017,70(Pt A),187-192","journal-title":"Epilepsy Behav"},{"key":"ref=5","first-page":"509","volume":"65","author":"Hirose G.","year":"2013","unstructured":"Hirose G.; An overview of epilepsy: its history, classification, pathophysiology and management Brain and nerve 2013,65,509-520","journal-title":"Brain and nerve"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s40263-018-0555-z","volume":"32","author":"Marmura M.J.","year":"2018","unstructured":"Marmura M.J.; Kumpinsky A.S.; Refining the benefit\/risk profile of anti-epileptic drugs in headache disorders. CNS Drugs 2018,32(8),735-746","journal-title":"CNS Drugs"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1535-7597.2002.t01-1-00052.x","volume":"2","author":"Dudek F.E.","year":"2002","unstructured":"Dudek F.E.; Role of glial cells in seizures and epilepsy: intracellular calcium oscillations and spatial buffering. Epilepsy Curr 2002,2(4),137-139","journal-title":"Epilepsy Curr"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","volume":"385","author":"Mosh\u00e9 S.L.","year":"2015","unstructured":"Mosh\u00e9 S.L.; Perucca E.; Ryvlin P.; Tomson T.; Epilepsy: new advances. Lancet 2015,385(9971),884-898","journal-title":"Lancet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0013-9580.2004.455005.x","volume":"45","author":"Sander J.W.","year":"2004","unstructured":"Sander J.W.; The use of antiepileptic drugs--principles and practice. Epilepsia 2004,45(Suppl. 6),28-34","journal-title":"Epilepsia"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yebeh.2017.06.031","volume":"74","author":"Villas N.","year":"2017","unstructured":"Villas N.; Meskis M.A.; Goodliffe S.; Dravet syndrome: Characteristics, comorbidities, and caregiver concerns. Epilepsy Behav 2017,74,81-86","journal-title":"Epilepsy Behav"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0733-8627(05)70157-7","volume":"18","author":"Yoon Y.","year":"2000","unstructured":"Yoon Y.; Jagoda A.; New antiepileptic drugs and preparations. Emerg Med Clin North Am 2000,18(4),755-765","journal-title":"Emerg Med Clin North Am"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/bs.apha.2017.02.002","volume":"79","author":"Chen R.","year":"2017","unstructured":"Chen R.; Buyan A.; Corry B.; Voltage-gated sodium channel pharmacology: insights from molecular dynamics simulations. Adv Pharmacol 2017,79,255-285","journal-title":"Adv Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2174\/1381612054021024","volume":"11","author":"Johnston G.A.","year":"2005","unstructured":"Johnston G.A.; GABA(A) receptor channel pharmacology. Curr Pharm Des 2005,11(15),1867-1885","journal-title":"Curr Pharm Des"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"107790","DOI":"10.1016\/j.neuropharm.2019.107790","volume":"168","author":"Janmohamed M.","year":"2020","unstructured":"Janmohamed M.; Brodie M.J.; Kwan P.; Pharmacoresistance - Epidemiology, mechanisms, and impact on epilepsy treatment. Neuropharmacology 2020,168,107790","journal-title":"Neuropharmacology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/NRL.0b013e3181dba5d3","volume":"16","author":"Guimar\u00e3es J.","year":"2010","unstructured":"Guimar\u00e3es J.; Ribeiro J.A.M.; Pharmacology of antiepileptic drugs in clinical practice. Neurologist 2010,16(6),353-357","journal-title":"Neurologist"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1085\/jgp.201511444","volume":"146","author":"Thiffault I.","year":"2015","unstructured":"Thiffault I.; Speca D.J.; Austin D.C.; Cobb M.M.; Eum K.S.; Safina N.P.; Grote L.; Farrow E.G.; Miller N.; Soden S.; Kingsmore S.F.; Trimmer J.S.; Saunders C.J.; Sack J.T.; A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localization. J Gen Physiol 2015,146(5),399-410","journal-title":"J Gen Physiol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5692\/clinicalneurol.cn-000963","volume":"57","author":"Sugiura Y.","year":"2017","unstructured":"Sugiura Y.; Ugawa Y.; Epilepsy and ion channels Rinsho Shinkeigaku 2017,57,1-8","journal-title":"Rinsho Shinkeigaku"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e0169974","DOI":"10.1371\/journal.pone.0169974","volume":"12","author":"Taing K.D.","year":"2017","unstructured":"Taing K.D.; O\u2019Brien T.J.; Williams D.A.; French C.R.; Anti-epileptic drug combination efficacy in an in vitro seizure model\u2013phenytoin and valproate, lamotrigine and valproate. PLoS One 2017,12(1),e0169974","journal-title":"PLoS One"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/187152409788452063","volume":"9","author":"Mula M.","year":"2009","unstructured":"Mula M.; New antiepileptic drugs: molecular targets Cent Nerv Sys Agents in Med Chem 2009,9,79-86","journal-title":"Cent Nerv Sys Agents in Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1152\/jn.01060.2015","volume":"116","author":"Zeng Z.","year":"2016","unstructured":"Zeng Z.; Hill-Yardin E.L.; Williams D.; O\u2019Brien T.; Serelis A.; French C.R.; Effect of phenytoin on sodium conductances in rat hippocampal CA1 pyramidal neurons. J Neurophysiol 2016,116(4),1924-1936","journal-title":"J Neurophysiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"6376","DOI":"10.2174\/1381612823666171115101557","volume":"23","author":"Carcak N.","year":"2017","unstructured":"Carcak N.; Ozkara C.; Seizures and antiepileptic drugs: from pathophysiology to clinical practice. Curr Pharm Des 2017,23(42),6376-6388","journal-title":"Curr Pharm Des"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.neuropharm.2006.12.004","volume":"52","author":"Mathers D.A.","year":"2007","unstructured":"Mathers D.A.; Wan X.; Puil E.; Barbiturate activation and modulation of GABA(A) receptors in neocortex. Neuropharmacology 2007,52(4),1160-1168","journal-title":"Neuropharmacology"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/j.1476-5381.2011.01456.x","volume":"164","author":"Chen C.R.","year":"2011","unstructured":"Chen C.R.; Tan R.; Qu W.M.; Wu Z.; Wang Y.; Urade Y.; Huang Z.L.; Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA\/benzodiazepine receptor complex in mice. Br J Pharmacol 2011,164(5),1534-1546","journal-title":"Br J Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.2174\/1381612823666170809100230","volume":"23","author":"Palma E.","year":"2017","unstructured":"Palma E.; Ruffolo G.; Cifelli P.; Roseti C.; Vliet E.A.V.; Aronica E.; Modulation of GABAA receptors in the treatment of epilepsy. Curr Pharm Des 2017,23(37),5563-5568","journal-title":"Curr Pharm Des"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ana.24967","volume":"82","author":"Torolira D.","year":"2017","unstructured":"Torolira D.; Suchomelova L.; Wasterlain C.G.; Niquet J.; Phenobarbital and midazolam increase neonatal seizure-associated neuronal injury. Ann Neurol 2017,82(1),115-120","journal-title":"Ann Neurol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1523\/JNEUROSCI.3697-16.2017","volume":"37","author":"Morris G.","year":"2017","unstructured":"Morris G.; Leite M.; Kullmann D.M.; Pavlov I.; Schorge S.; Lignani G.; Activity clamp provides insights into paradoxical effects of the anti-seizure drug carbamazepine. J Neurosci 2017,37(22),5484-5495","journal-title":"J Neurosci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1517\/14656566.2016.1168399","volume":"17","author":"Gierbolini J.","year":"2016","unstructured":"Gierbolini J.; Giarratano M.; Benbadis S.R.; Carbamazepine-related antiepileptic drugs for the treatment of epilepsy - a comparative review. Expert Opin Pharmacother 2016,17(7),885-888","journal-title":"Expert Opin Pharmacother"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1523\/JNEUROSCI.22-06-02023.2002","volume":"22","author":"Sidach S.S.","year":"2002","unstructured":"Sidach S.S.; Mintz I.M.; Kurtoxin, a gating modifier of neuronal high- and low-threshold Ca channels. J Neurosci 2002,22(6),2023-2034","journal-title":"J Neurosci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/epi.12118","volume":"54","author":"Dezsi G.","year":"2013","unstructured":"Dezsi G.; Ozturk E.; Stanic D.; Powell K.L.; Blumenfeld H.; O\u2019Brien T.J.; Jones N.C.; Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy. Epilepsia 2013,54(4),635-643","journal-title":"Epilepsia"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"121ra19","DOI":"10.1126\/scitranslmed.3003120","volume":"4","author":"Tringham E.","year":"2012","unstructured":"Tringham E.; Powell K. L.; Cain S. M.; Kuplast K.; Mezeyova J.; Weerapura M.; Jones N. C.; T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures Sci Transl Med 2012,4,121ra19-121ra19","journal-title":"Sci Transl Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.24886","volume":"81","author":"Glauser T.A.","year":"2017","unstructured":"Glauser T.A.; Holland K.; O\u2019Brien V.P.; Keddache M.; Martin L.J.; Clark P.O.; Cnaan A.; Dlugos D.; Hirtz D.G.; Shinnar S.; Grabowski G.; Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. Ann Neurol Childhood Absence Epilepsy Study Group2017,81(3),444-453","journal-title":"Ann Neurol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.epilep.2012.11.004","volume":"1","author":"Potschka H.","year":"2013","unstructured":"Potschka H.; Pharmacological treatment strategies: mechanisms of antiepileptic drugs. Epileptology 2013,1,31-37","journal-title":"Epileptology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.seizure.2010.10.027","volume":"19","author":"Brodie M.J.","year":"2010","unstructured":"Brodie M.J.; Antiepileptic drug therapy the story so far. Seizure 2010,19(10),650-655","journal-title":"Seizure"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1684\/epd.2016.0861","volume":"18","author":"Michelucci R.","year":"2016","unstructured":"Michelucci R.; Pasini E.; Riguzzi P.; Andermann E.; K\u00e4lvi\u00e4inen R.; Genton P.; Myoclonus and seizures in progressive myoclonus epilepsies: pharmacology and therapeutic trials. Epileptic Disord 2016,18(S2),145-153","journal-title":"Epileptic Disord"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11910-016-0678-x","volume":"16","author":"Brodie M.J.","year":"2016","unstructured":"Brodie M.J.; Pharmacological treatment of drug-resistant epilepsy in adults: a practical guide. Curr Neurol Neurosci Rep 2016,16(9),82","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=36","doi-asserted-by":"publisher","author":"LaGrotta C.","unstructured":"LaGrotta C.; Thomas A.;  Benzodiazepines and other sedatives, hypnotics, and anxiolytics. In: Marienfeld C. (eds) Absolute Addiction Psychiatry Review. Springer, Cham, 2020, pp. 139-51","DOI":"10.1007\/978-3-030-33404-8_9"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1586\/14737175.2015.1056781","volume":"15","author":"Shangguan Y.","year":"2015","unstructured":"Shangguan Y.; Liao H.; Wang X.; Clonazepam in the treatment of status epilepticus. Expert Rev Neurother 2015,15(7),733-740","journal-title":"Expert Rev Neurother"},{"key":"ref=38","first-page":"123","author":"Simeone T.A.","year":"2010","unstructured":"Simeone T.A.;  Mechanisms of antiepileptic drug action Epilepsy: mechanisms, models, and translational perspectives 2010,123-141","journal-title":"Mechanisms of antiepileptic drug action Epilepsy: mechanisms, models, and translational perspectives"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1528-1167.2005.00324.x","volume":"46","author":"Benbadis S.R.","year":"2005","unstructured":"Benbadis S.R.; Practical management issues for idiopathic generalized epilepsies. Epilepsia 2005,46(Suppl. 9),125-132","journal-title":"Epilepsia"},{"key":"ref=40","first-page":"857","volume":"15","author":"Sheybani L.","year":"2019","unstructured":"Sheybani L.; Mercier N.; Vulli\u00e9moz S.; Pharmacology and epilepsy\u2005: update on the new antiepileptic drugs. Rev Med Suisse 2019,15(648),857-861","journal-title":"Rev Med Suisse"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.addr.2011.12.007","volume":"64","author":"Potschka H.","year":"2012","unstructured":"Potschka H.; Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport. Adv Drug Deliv Rev 2012,64(10),943-952","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/molecules24081459","volume":"24","author":"Silvestro S.","year":"2019","unstructured":"Silvestro S.; Mammana S.; Cavalli E.; Bramanti P.; Mazzon E.; Use of cannabidiol in the treatment of epilepsy: Efficacy and security in clinical trials. Molecules 2019,24(8),1459","journal-title":"Molecules"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.epilep.2012.11.001","volume":"1","author":"Yacubian E.M.T.","year":"2013","unstructured":"Yacubian E.M.T.; de Ara\u00fajo Filho G.M.; Management issues for patients with idiopathic generalized epilepsies. Epileptology 2013,1,1-10","journal-title":"Epileptology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.neubiorev.2006.03.002","volume":"30","author":"van Luijtelaar G.","year":"2006","unstructured":"van Luijtelaar G.; Sitnikova E.; Global and focal aspects of absence epilepsy: The contribution of genetic models. Neurosci Biobehav Rev 2006,30(7),983-1003","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/B978-0-444-52899-5.00021-6","volume":"108","author":"Porter R.J.","year":"2012","unstructured":"Porter R.J.; Dhir A.; Macdonald R.L.; Rogawski M.A.; Mechanisms of action of antiseizure drugs. Handb Clin Neurol 2012,108,663-681","journal-title":"Handb Clin Neurol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/B978-0-12-385467-4.00012-9","volume":"7","author":"Luke M.","year":"2012","unstructured":"Luke M.;  Therapeutic drug monitoring: newer drugs and biomarkers 2012,7,243-267","journal-title":"Therapeutic drug monitoring: newer drugs and biomarkers"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1124\/jpet.119.261222","volume":"372","author":"Leclercq K.","year":"2020","unstructured":"Leclercq K.; Matagne A.; Provins L.; Klitgaard H.; Kaminski R.M.; Pharmacological profile of the novel antiepileptic drug candidate padsevonil: characterization in rodent seizure and epilepsy models. J Pharmacol Exp Ther 2020,372(1),11-20","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"e00124","DOI":"10.1002\/prp2.124","volume":"3","author":"Soares-da-Silva P.","year":"2015","unstructured":"Soares-da-Silva P.; Pires N.; Bonif\u00e1cio M.J.; Loureiro A.I.; Palma N.; Wright L.C.; Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action. Pharmacol Res Perspect 2015,3(2),e00124","journal-title":"Pharmacol Res Perspect"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ebiom.2018.02.013","volume":"29","author":"Kitaura H.","year":"2018","unstructured":"Kitaura H.; Shirozu H.; Masuda H.; Fukuda M.; Fujii Y.; Kakita A.; Pathophysiological characteristics associated with epileptogenesis in human hippocampal sclerosis. EBioMedicine 2018,29,38-46","journal-title":"EBioMedicine"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e2209","DOI":"10.1212\/WNL.0000000000007447","volume":"92","author":"Bernhardt B.C.","year":"2019","unstructured":"Bernhardt B.C.; Fadaie F.; Liu M.; Caldairou B.; Gu S.; Jefferies E.; Smallwood J.; Bassett D.S.; Bernasconi A.; Bernasconi N.; Temporal lobe epilepsy: Hippocampal pathology modulates connectome topology and controllability. Neurology 2019,92(19),e2209-e2220","journal-title":"Neurology"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ph11010017","volume":"11","author":"Jarero-Basulto J.J.","year":"2018","unstructured":"Jarero-Basulto J.J.; Gasca-Mart\u00ednez Y.; Rivera-Cervantes M.C.; Ure\u00f1a-Guerrero M.E.; Feria-Velasco A.I.; Beas-Zarate C.; Interactions between epilepsy and plasticity. Pharmaceuticals (Basel) 2018,11(1),17","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12868-016-0296-1","volume":"17","author":"Hamadi N.","year":"2016","unstructured":"Hamadi N.; Sheikh A.; Madjid N.; Lubbad L.; Amir N.; Shehab S.A.D.S.; Khelifi-Touhami F.; Adem A.; Increased pro-inflammatory cytokines, glial activation and oxidative stress in the hippocampus after short-term bilateral adrenalectomy. BMC Neurosci 2016,17(1),61","journal-title":"BMC Neurosci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","volume":"4","author":"Devinsky O.","year":"2018","unstructured":"Devinsky O.; Vezzani A.; O\u2019Brien T.J.; Jette N.; Scheffer I.E.; de Curtis M.; Perucca P.; Epilepsy. Nat Rev Dis Primers 2018,4,18024","journal-title":"Nat Rev Dis Primers"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1208\/s12248-017-0096-2","volume":"19","author":"Han H.","year":"2017","unstructured":"Han H.; Mann A.; Ekstein D.; Eyal S.; Breaking bad: the structure and function of the blood-brain barrier in epilepsy. AAPS J 2017,19(4),973-988","journal-title":"AAPS J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nbd.2018.06.022","volume":"123","author":"Dadas A.","year":"2019","unstructured":"Dadas A.; Janigro D.; Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy. Neurobiol Dis 2019,123,20-26","journal-title":"Neurobiol Dis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fneur.2017.00301","volume":"8","author":"Tang F.","year":"2017","unstructured":"Tang F.; Hartz A.M.S.; Bauer B.; Drug-resistant epilepsy: multiple hypotheses, few answers. Front Neurol 2017,8,301","journal-title":"Front Neurol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.seizure.2018.07.011","volume":"61","author":"Bj\u00f8rke A.B.","year":"2018","unstructured":"Bj\u00f8rke A.B.; Nome C.G.; Falk R.S.; Gjerstad L.; Taub\u00f8ll E.; Heuser K.; Evaluation of long-term antiepileptic drug use in patients with temporal lobe epilepsy: Assessment of risk factors for drug resistance and polypharmacy. Seizure 2018,61,63-70","journal-title":"Seizure"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2174\/1871527317666180828121820","volume":"17","author":"Deng X.","year":"2018","unstructured":"Deng X.; Xie Y.; Chen Y.; Effect of neuroinflammation on ABC transporters: possible contribution to refractory epilepsy. CNS Neurol Disord Drug Targets 2018,17(10),728-735","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/dna.2018.4553","volume":"38","author":"Shen X.M.","year":"2019","unstructured":"Shen X.M.; Cheng J.; Effects of MDR1 (C3435T) polymorphism on resistance, uptake, and efflux to antiepileptic drugs. DNA Cell Biol 2019,38(3),250-255","journal-title":"DNA Cell Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1124\/dmd.114.059055","volume":"42","author":"Uchida Y.","year":"2014","unstructured":"Uchida Y.; Ohtsuki S.; Terasaki T.; Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models. Drug Metab Dispos 2014,42(10),1719-1726","journal-title":"Drug Metab Dispos"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3389\/fnins.2018.00602","volume":"12","author":"Xie Y.","year":"2018","unstructured":"Xie Y.; Shao Y.; Deng X.; Wang M.; Chen Y.; MicroRNA-298 reverses multidrug resistance to antiepileptic drugs by suppressing MDR1\/P-gp expression in vitro. Front Neurosci 2018,12,602","journal-title":"Front Neurosci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.omtn.2019.10.042","volume":"19","author":"Zamay T. N.","unstructured":"Zamay T. N.; Zamay G. S.; Shnayder N. A.; Dmitrenko D. V.; Zamay S. S.; Yushchenko V.; Kichkailo A. S.; Nucleic acid aptamers for molecular therapy of epilepsy and blood\u2013brain barrier damages Mole Ther Nucleic Acids ,19,157-167","journal-title":"Mole Ther Nucleic Acids"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.phrs.2019.04.031","volume":"144","author":"Leandro K.","year":"2019","unstructured":"Leandro K.; Bicker J.; Alves G.; Falc\u00e3o A.; Fortuna A.; ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches. Pharmacol Res 2019,144,357-376","journal-title":"Pharmacol Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.neuropharm.2009.01.009","volume":"56","author":"Zibell G.","year":"2009","unstructured":"Zibell G.; Unkr\u00fcer B.; Pekcec A.; Hartz A.M.; Bauer B.; Miller D.S.; Potschka H.; Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition. Neuropharmacology 2009,56(5),849-855","journal-title":"Neuropharmacology"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"105378","DOI":"10.1016\/j.tvjl.2019.105378","volume":"253","author":"Gagliardo T.","year":"2019","unstructured":"Gagliardo T.; Gandini G.; Gallucci A.; Menchetti M.; Bianchi E.; Turba M.E.; Cauduro A.; Corlazzoli D.S.; Gianni S.; Baroni M.; Bernardini M.; Gentilini F.; ABCB1 c.-6-180T>G polymorphism and clinical risk factors in a multi-breed cohort of dogs with refractory idiopathic epilepsy. Vet J 2019,253,105378","journal-title":"Vet J"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/jcbfm.2008.16","volume":"28","author":"Bauer B.","year":"2008","unstructured":"Bauer B.; Hartz A.M.; Lucking J.R.; Yang X.; Pollack G.M.; Miller D.S.; Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J Cereb Blood Flow Metab 2008,28(6),1222-1234","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s11064-017-2224-x","volume":"42","author":"Yu N.","year":"2017","unstructured":"Yu N.; Zhang Y.F.; Zhang K.; Cheng Y.F.; Ma H.Y.; Di Q.; Pregnane X receptor not nuclear factor-kappa B up-regulates P-glycoprotein expression in the brain of chronic epileptic rats induced by kainic acid. Neurochem Res 2017,42(8),2167-2177","journal-title":"Neurochem Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.plefa.2011.04.003","volume":"85","author":"Rehni A.K.","year":"2011","unstructured":"Rehni A.K.; Singh T.G.; Modulation of leukotriene D4 attenuates the development of seizures in mice. Prostaglandins Leukot Essent Fatty Acids 2011,85(2),97-106","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1343650","DOI":"10.1155\/2019\/1343650","volume":"2019","author":"Chouchi M.","year":"2019","unstructured":"Chouchi M.; Klaa H.; Ben-Youssef Turki I.; Hila L.; \n                        ABCB1 Polymorphisms and Drug-Resistant Epilepsy in a Tunisian Population. Dis Markers 2019,2019,1343650","journal-title":"Dis Markers"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nrl.2015.03.005","volume":"33","author":"Fricke-Galindo I.","year":"2018","unstructured":"Fricke-Galindo I.; Jung-Cook H.; LLerena A.; L\u00f3pez-L\u00f3pez M.; Pharmacogenetics of adverse reactions to antiepileptic drugs. Neurologia 2018,33(3),165-176","journal-title":"Neurologia"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2741\/713","volume":"6","author":"Lopez-Garcia M.A.","year":"2014","unstructured":"Lopez-Garcia M.A.; Feria-Romero I.A.; Fernando-Serrano H.; Escalante-Santiago D.; Grijalva I.; Orozco-Suarez S.; Genetic polymorphisms associated with antiepileptic metabolism. Front Biosci (Elite Ed) 2014,6,377-386","journal-title":"Front Biosci (Elite Ed)"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12028-018-0663-0","volume":"31","author":"M\u00f8ller H.S.","year":"2019","unstructured":"M\u00f8ller H.S.; Rodin E.; Aukland P.; Lando M.; Christiansen E.B.; Beier C.P.; Epidemiology-based mortality score is associated with long-term mortality after status epilepticus. Neurocrit Care 2019,31(1),135-141","journal-title":"Neurocrit Care"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12028-017-0460-1","volume":"27","author":"Claassen J.","year":"2017","unstructured":"Claassen J.; Goldstein J.N.; Emergency neurological life support: status epilepticus. Neurocrit Care 2017,27(Suppl. 1),152-158","journal-title":"Neurocrit Care"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1142\/S0192415X17500331","volume":"45","author":"Wang J.","year":"2017","unstructured":"Wang J.; Li Y.; Huang W.H.; Zeng X.C.; Li X.H.; Li J.; Zhou J.; Xiao J.; Xiao B.; Ouyang D.S.; Hu K.; The protective effect of aucubin from eucommia ulmoides against status epilepticus by inducing autophagy and inhibiting necroptosis. Am J Chin Med 2017,45(3),557-573","journal-title":"Am J Chin Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"6736721","DOI":"10.1155\/2018\/6736721","volume":"2018","author":"Dutra M.R.H.","year":"2018","unstructured":"Dutra M.R.H.; Feliciano R.D.S.; Jacinto K.R.; Gouveia T.L.F.; Brigidio E.; Serra A.J.; Morris M.; Naffah-Mazzacoratti M.D.G.; Silva J.A.; Protective role of UCP2 in oxidative stress and apoptosis during the silent phase of an experimental model of epilepsy induced by pilocarpine. Oxid Med Cell Longev 2018,2018,6736721","journal-title":"Oxid Med Cell Longev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/CON.0000000000000668","volume":"24","author":"Nelson S.E.","year":"2018","unstructured":"Nelson S.E.; Varelas P.N.; Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Continuum (Minneap Minn) 2018,24(6),1683-1707","journal-title":"Continuum (Minneap Minn)"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neures.2017.08.004","volume":"130","author":"Li Q.","year":"2018","unstructured":"Li Q.; Han Y.; Du J.; Jin H.; Zhang J.; Niu M.; Qin J.; Alterations of apoptosis and autophagy in developing brain of rats with epilepsy: Changes in LC3, P62, Beclin-1 and Bcl-2 levels. Neurosci Res 2018,130,47-55","journal-title":"Neurosci Res"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-1236-z","volume":"10","author":"Wang Z.","year":"2019","unstructured":"Wang Z.; Zhou L.; An D.; Xu W.; Wu C.; Sha S.; Chen L.; TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice. Cell Death Dis 2019,10,1-10","journal-title":"Cell Death Dis"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.brainresbull.2018.11.013","volume":"144","author":"Singh N.","year":"2019","unstructured":"Singh N.; Saha L.; Kumari P.; Singh J.; Bhatia A.; Banerjee D.; Chakrabarti A.; Effect of dimethyl fumarate on neuroinflammation and apoptosis in pentylenetetrazol kindling model in rats. Brain Res Bull 2019,144,233-245","journal-title":"Brain Res Bull"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1134\/S0006297918100036","volume":"83","author":"Sibarov D.A.","year":"2018","unstructured":"Sibarov D.A.; Antonov S.M.; Calcium-dependent desensitization of NMDA receptors. Biochemistry (Mosc) 2018,83(10),1173-1183","journal-title":"Biochemistry (Mosc)"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/cells7120229","volume":"7","author":"Zhou Z.","year":"2018","unstructured":"Zhou Z.; Austin G.L.; Young L.E.A.; Johnson L.A.; Sun R.; Mitochondrial metabolism in major neurological diseases. Cells 2018,7(12),229","journal-title":"Cells"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2017.10.009","volume":"1678","author":"Wang B.H.","year":"2018","unstructured":"Wang B.H.; Hou Q.; Lu Y.Q.; Jia M.M.; Qiu T.; Wang X.H.; Zhang Z.X.; Jiang Y.; Ketogenic diet attenuates neuronal injury via autophagy and mitochondrial pathways in pentylenetetrazol-kindled seizures. Brain Res 2018,1678,106-115","journal-title":"Brain Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-94-017-8914-1_9","volume":"813","author":"Dingledine R.","year":"2014","unstructured":"Dingledine R.; Varvel N.H.; Dudek F.E.; When and how do seizures kill neurons, and is cell death relevant to epileptogenesis? Adv Exp Med Biol 2014,813(813),109-122","journal-title":"Adv Exp Med Biol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"Glick D.","year":"2010","unstructured":"Glick D.; Barth S.; Macleod K.F.; Autophagy: cellular and molecular mechanisms. J Pathol 2010,221(1),3-12","journal-title":"J Pathol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.yebeh.2017.05.025","volume":"75","author":"Cai Q.","year":"2017","unstructured":"Cai Q.; Gan J.; Luo R.; Qu Y.; Li S.; Wan C.; Mu D.; The role of necroptosis in status epilepticus-induced brain injury in juvenile rats. Epilepsy Behav 2017,75,134-142","journal-title":"Epilepsy Behav"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fphys.2014.00323","volume":"5","author":"Marshall K.D.","year":"2014","unstructured":"Marshall K.D.; Baines C.P.; Necroptosis: is there a role for mitochondria? Front Physiol 2014,5,323","journal-title":"Front Physiol"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-981-10-5311-5_2","author":"Olive M.F.","year":"2019","unstructured":"Olive M.F.; Powell G.; McClure E.; Gipson C.D.; Neurotransmitter Systems: Glutamate The Therapeutic Use of N-Acetylcysteine (NAC) in Medicine 2019,19-28","journal-title":"The Therapeutic Use of N-Acetylcysteine (NAC) in Medicine"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.biocel.2018.12.006","volume":"107","author":"Hotka M.","year":"2019","unstructured":"Hotka M.; Kubista H.; The paroxysmal depolarization shift in epilepsy research. Int J Biochem Cell Biol 2019,107,77-81","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"104485","DOI":"10.1016\/j.nbd.2019.104485","volume":"130","author":"Gonz\u00e1lez O.C.","year":"2019","unstructured":"Gonz\u00e1lez O.C.; Krishnan G.P.; Timofeev I.; Bazhenov M.; Ionic and synaptic mechanisms of seizure generation and epileptogenesis. Neurobiol Dis 2019,130,104485","journal-title":"Neurobiol Dis"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nn.3947","volume":"18","author":"Staley K.","year":"2015","unstructured":"Staley K.; Molecular mechanisms of epilepsy. Nat Neurosci 2015,18(3),367-372","journal-title":"Nat Neurosci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neuropharm.2015.09.032","volume":"101","author":"Sakkaki S.","year":"2016","unstructured":"Sakkaki S.; Gangarossa G.; Lerat B.; Fran\u00e7on D.; Forichon L.; Chemin J.; Valjent E.; Lerner-Natoli M.; Lory P.; Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model. Neuropharmacology 2016,101,320-329","journal-title":"Neuropharmacology"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/19336950.2017.1358836","volume":"11","author":"Cain S.M.","year":"2017","unstructured":"Cain S.M.; Garcia E.; Waheed Z.; Jones K.L.; Bushell T.J.; Snutch T.P.; GABA receptors suppress burst-firing in reticular thalamic neurons. Channels (Austin) 2017,11(6),574-586","journal-title":"Channels (Austin)"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2174\/1381612825666190319121505","volume":"25","author":"Werner F.M.","year":"2019","unstructured":"Werner F.M.; Cove\u00f1as R.; Neural networks in generalized epilepsy and novel antiepileptic drugs. Curr Pharm Des 2019,25(4),396-400","journal-title":"Curr Pharm Des"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2174\/1570159X13666150515234920","volume":"14","author":"Peterlik D.","year":"2016","unstructured":"Peterlik D.; Flor P.J.; Uschold-Schmidt N.; The emerging role of metabotropic glutamate receptors in the pathophysiology of chronic stress-related disorders. Curr Neuropharmacol 2016,14(5),514-539","journal-title":"Curr Neuropharmacol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.nbd.2005.05.019","volume":"20","author":"Sfaello I.","year":"2005","unstructured":"Sfaello I.; Baud O.; Arzimanoglou A.; Gressens P.; Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 2005,20(3),837-848","journal-title":"Neurobiol Dis"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1177\/1087057114541149","volume":"19","author":"Fukushima K.","year":"2014","unstructured":"Fukushima K.; Tabata Y.; Imaizumi Y.; Kohmura N.; Sugawara M.; Sawada K.; Yamazaki K.; Ito M.; Characterization of human hippocampal neural stem\/progenitor cells and their application to physiologically relevant assays for multiple ionotropic glutamate receptors. J Biomol Screen 2014,19(8),1174-1184","journal-title":"J Biomol Screen"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"a022871","DOI":"10.1101\/cshperspect.a022871","volume":"6","author":"K\u00f6hling R.","year":"2016","unstructured":"K\u00f6hling R.; Wolfart J.; Potassium channels in epilepsy. Cold Spring Harb Perspect Med 2016,6(5),a022871","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.braindev.2008.05.010","volume":"31","author":"Ishii A.","year":"2009","unstructured":"Ishii A.; Fukuma G.; Uehara A.; Miyajima T.; Makita Y.; Hamachi A.; Yasukochi M.; Inoue T.; Yasumoto S.; Okada M.; Kaneko S.; Mitsudome A.; Hirose S.; A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions. Brain Dev 2009,31(1),27-33","journal-title":"Brain Dev"},{"key":"ref=99","first-page":"225","volume":"2","author":"Barrese V.","year":"2010","unstructured":"Barrese V.; Miceli F.; Soldovieri M.V.; Ambrosino P.; Iannotti F.A.; Cilio M.R.; Taglialatela M.; Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine. Clin Pharmacol 2010,2,225-236","journal-title":"Clin Pharmacol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"11349","DOI":"10.1096\/fj.201900485R","volume":"33","author":"Manville R.W.","year":"2019","unstructured":"Manville R.W.; Abbott G.W.; Cilantro leaf harbors a potent potassium channel-activating anticonvulsant. FASEB J 2019,33(10),11349-11363","journal-title":"FASEB J"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"247a","DOI":"10.1016\/j.bpj.2018.11.1351","volume":"116","author":"Pantazis A.","year":"2019","unstructured":"Pantazis A.; Kaneko M.; Westerlund A.M.; Delemotte L.; Saitta S.; Olcese R.; A De Novo Mutation Associated with Epilepsy Enhances KV1. 2 Voltage Dependence, Suppressing Neuronal Excitability. Biophys J 2019,116,247a","journal-title":"Biophys J"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/09687680110047373","volume":"18","author":"Liss B.","year":"2001","unstructured":"Liss B.; Roeper J.; Molecular physiology of neuronal K-ATP channels (review). Mol Membr Biol 2001,18(2),117-127","journal-title":"Mol Membr Biol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/j.1471-4159.2007.04883.x","volume":"103","author":"Soundarapandian M.M.","year":"2007","unstructured":"Soundarapandian M.M.; Wu D.; Zhong X.; Petralia R.S.; Peng L.; Tu W.; Lu Y.; Expression of functional Kir6.1 channels regulates glutamate release at CA3 synapses in generation of epileptic form of seizures. J Neurochem 2007,103(5),1982-1988","journal-title":"J Neurochem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jnr.21284","volume":"85","author":"Huang C.W.","year":"2007","unstructured":"Huang C.W.; Huang C.C.; Cheng J.T.; Tsai J.J.; Wu S.N.; Glucose and hippocampal neuronal excitability: role of ATP-sensitive potassium channels. J Neurosci Res 2007,85(7),1468-1477","journal-title":"J Neurosci Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/fcp.12490","volume":"34","author":"Mohammadi F.","year":"2020","unstructured":"Mohammadi F.; Shakiba S.; Mehrzadi S.; Afshari K.; Rahimnia A.H.; Dehpour A.R.; Anticonvulsant effect of melatonin through ATP-sensitive channels in mice. Fundam Clin Pharmacol 2020,34(1),148-155","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"H33","DOI":"10.1152\/ajpheart.01088.2010","volume":"300","author":"Hund T.J.","year":"2011","unstructured":"Hund T.J.; Mohler P.J.; Differential roles for SUR subunits in KATP channel membrane targeting and regulation. Am J Physiol Heart Circ Physiol 2011,300(1),H33-H35","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"14490","DOI":"10.1073\/pnas.1003072107","volume":"107","author":"Reichold M.","year":"2010","unstructured":"Reichold M.; Zdebik A.A.; Lieberer E.; Rapedius M.; Schmidt K.; Bandulik S.; Sterner C.; Tegtmeier I.; Penton D.; Baukrowitz T.; Hulton S.A.; Witzgall R.; Ben-Zeev B.; Howie A.J.; Kleta R.; Bockenhauer D.; Warth R.; KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. Proc Natl Acad Sci USA 2010,107(32),14490-14495","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0028-3908(02)00237-X","volume":"43","author":"Wickenden A.D.","year":"2002","unstructured":"Wickenden A.D.; Potassium channels as anti-epileptic drug targets. Neuropharmacology 2002,43(7),1055-1060","journal-title":"Neuropharmacology"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1126\/science.1059829","volume":"292","author":"Yamada K.","year":"2001","unstructured":"Yamada K.; Ji J.J.; Yuan H.; Miki T.; Sato S.; Horimoto N.; Shimizu T.; Seino S.; Inagaki N.; Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 2001,292(5521),1543-1546","journal-title":"Science"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/glia.23247","volume":"66","author":"Boison D.","year":"2018","unstructured":"Boison D.; Steinh\u00e4user C.; Epilepsy and astrocyte energy metabolism. Glia 2018,66(6),1235-1243","journal-title":"Glia"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"104627","DOI":"10.1016\/j.neuint.2019.104627","volume":"133","author":"Higashi H.","year":"2020","unstructured":"Higashi H.; Kinjo T.; Uno K.; Kuramoto N.; Regulatory effects associated with changes in intracellular potassium level in susceptibility to mitochondrial depolarization and excitotoxicity. Neurochem Int 2020,133,104627","journal-title":"Neurochem Int"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.yebeh.2016.07.014","volume":"62","author":"Sheikhi M.","year":"2016","unstructured":"Sheikhi M.; Shirzadian A.; Dehdashtian A.; Amiri S.; Ostadhadi S.; Ghasemi M.; Dehpour A.R.; Involvement of ATP-sensitive potassium channels and the opioid system in the anticonvulsive effect of zolpidem in mice. Epilepsy Behav 2016,62,291-296","journal-title":"Epilepsy Behav"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0306-4522(94)90177-5","volume":"59","author":"Egberongbe Y.I.","year":"1994","unstructured":"Egberongbe Y.I.; Gentleman S.M.; Falkai P.; Bogerts B.; Polak J.M.; Roberts G.W.; The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 1994,59(3),561-578","journal-title":"Neuroscience"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N","volume":"29","author":"Murphy S.","year":"2000","unstructured":"Murphy S.; Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 2000,29(1),1-13","journal-title":"Glia"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.bbadis.2018.11.007","volume":"1865","author":"Pic\u00f3n-Pag\u00e8s P.","year":"2019","unstructured":"Pic\u00f3n-Pag\u00e8s P.; Garcia-Buendia J.; Mu\u00f1oz F.J.; Functions and dysfunctions of nitric oxide in brain. Biochim Biophys Acta Mol Basis Dis 2019,1865(8),1949-1967","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.fct.2018.08.028","volume":"121","author":"Cui J.","year":"2018","unstructured":"Cui J.; Wang G.; Kandhare A.D.; Mukherjee-Kandhare A.A.; Bodhankar S.L.; Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-\u03b3, Bax\/Bcl-2, and caspase-3. Food Chem Toxicol 2018,121,95-108","journal-title":"Food Chem Toxicol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neuroscience.2019.03.002","volume":"406","author":"Yu T.","year":"2019","unstructured":"Yu T.; Yu H.; Zhang B.; Wang D.; Li B.; Zhu J.; Zhu W.; Promising neuroprotective function for m2 microglia in kainic acid-induced neurotoxicity via the down-regulation of NF-\u03baB and caspase 3 signaling pathways. Neuroscience 2019,406,86-96","journal-title":"Neuroscience"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3988\/jcn.2015.11.3.212","volume":"11","author":"Paillard T.","year":"2015","unstructured":"Paillard T.; Rolland Y.; de Souto Barreto P.; Protective effects of physical exercise in Alzheimer\u2019s disease and Parkinson\u2019s disease: a narrative review. J Clin Neurol 2015,11(3),212-219","journal-title":"J Clin Neurol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1528-1157.2001.083032.x","volume":"42","author":"Yasuda H.","year":"2001","unstructured":"Yasuda H.; Fujii M.; Fujisawa H.; Ito H.; Suzuki M.; Changes in nitric oxide synthesis and epileptic activity in the contralateral hippocampus of rats following intrahippocampal kainate injection. Epilepsia 2001,42(1),13-20","journal-title":"Epilepsia"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0006-8993(03)03034-8","volume":"981","author":"Gupta R.C.","year":"2003","unstructured":"Gupta R.C.; Dettbarn W.D.; Prevention of kainic acid seizures-induced changes in levels of nitric oxide and high-energy phosphates by 7-nitroindazole in rat brain regions. Brain Res 2003,981(1-2),184-192","journal-title":"Brain Res"},{"key":"ref=121","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/293689","author":"M\u00e9ndez-Armenta M.","year":"2014","unstructured":"M\u00e9ndez-Armenta M.; Nava-Ru\u00edz C.; Ju\u00e1rez-Rebollar D.; Rodr\u00edguez-Mart\u00ednez E.; Yescas G\u00f3mez P.; Oxidative stress associated with neuronal apoptosis in experimental models of epilepsy Oxi Med Cellular longev 2014","journal-title":"Oxi Med Cellular longev"},{"key":"ref=122","first-page":"535","volume":"55","author":"Wojtal K.","year":"2003","unstructured":"Wojtal K.; Gniatkowska-Nowakowska A.; Czuczwar S.J.; Is nitric oxide involved in the anticonvulsant action of antiepileptic drugs? Pol J Pharmacol 2003,55(4),535-542","journal-title":"Pol J Pharmacol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.niox.2009.06.001","volume":"21","author":"Rehni A.K.","year":"2009","unstructured":"Rehni A.K.; Singh T.G.; Kalra R.; Singh N.; Pharmacological inhibition of inducible nitric oxide synthase attenuates the development of seizures in mice. Nitric Oxide 2009,21(2),120-125","journal-title":"Nitric Oxide"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2174\/187152711798072347","volume":"10","author":"Banach M.","year":"2011","unstructured":"Banach M.; Piskorska B.; Czuczwar S.J.; Borowicz K.K.; Nitric oxide, epileptic seizures, and action of antiepileptic drugs. CNS Neurol Disord Drug Targets 2011,10(7),808-819","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.yebeh.2016.08.001","volume":"65","author":"Mohseni G.","year":"2016","unstructured":"Mohseni G.; Ostadhadi S.; Akbarian R.; Chamanara M.; Norouzi-Javidan A.; Dehpour A.R.; Anticonvulsant effect of dextrometrophan on pentylenetetrazole-induced seizures in mice: Involvement of nitric oxide and N-methyl-d-aspartate receptors. Epilepsy Behav 2016,65,49-55","journal-title":"Epilepsy Behav"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0014-2999(00)00086-8","volume":"394","author":"De Sarro G.","year":"2000","unstructured":"De Sarro G.; Gareri P.; Falconi U.; De Sarro A.; 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA\/2 mice. Eur J Pharmacol 2000,394(2-3),275-288","journal-title":"Eur J Pharmacol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fncel.2014.00430","volume":"8","author":"Calabrese F.","year":"2014","unstructured":"Calabrese F.; Rossetti A.C.; Racagni G.; Gass P.; Riva M.A.; Molteni R.; Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci 2014,8,430","journal-title":"Front Cell Neurosci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/01.CIR.101.4.439","volume":"101","author":"Sasaki N.","year":"2000","unstructured":"Sasaki N.; Sato T.; Ohler A.; O\u2019Rourke B.; Marb\u00e1n E.; Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 2000,101(4),439-445","journal-title":"Circulation"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/aps.2012.138","volume":"34","author":"Sun H.S.","year":"2013","unstructured":"Sun H.S.; Feng Z.P.; Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia. Acta Pharmacol Sin 2013,34(1),24-32","journal-title":"Acta Pharmacol Sin"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","volume":"2","author":"Robson S.C.","year":"2006","unstructured":"Robson S.C.; S\u00e9vigny J.; Zimmermann H.; The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2006,2(2),409-430","journal-title":"Purinergic Signal"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainresbull.2019.01.030","volume":"151","author":"Huang L.","year":"2019","unstructured":"Huang L.; Otrokocsi L.; Sperl\u00e1gh B.; Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders. Brain Res Bull 2019,151,55-64","journal-title":"Brain Res Bull"},{"key":"ref=132","first-page":"174","volume":"4","author":"Engel T.","year":"2012","unstructured":"Engel T.; Jimenez-Pacheco A.; Miras-Portugal M.T.; Diaz-Hernandez M.; Henshall D.C.; P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control. Int J Physiol Pathophysiol Pharmacol 2012,4(4),174-187","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.3892\/mmr.2019.10202","volume":"19","author":"Song P.","year":"2019","unstructured":"Song P.; Hu J.; Liu X.; Deng X.; Increased expression of the P2X7 receptor in temporal lobe epilepsy: Animal models and clinical evidence. Mol Med Rep 2019,19(6),5433-5439","journal-title":"Mol Med Rep"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"e0156468","DOI":"10.1371\/journal.pone.0156468","volume":"11","author":"Fischer W.","year":"2016","unstructured":"Fischer W.; Franke H.; Kr\u00fcgel U.; M\u00fcller H.; Dinkel K.; Lord B.; Letavic M.A.; Henshall D.C.; Engel T.; Critical evaluation of P2X7 receptor antagonists in selected seizure models. PLoS One 2016,11(6),e0156468","journal-title":"PLoS One"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.08.001","volume":"140","author":"Khan M.T.","year":"2018","unstructured":"Khan M.T.; Liu J.; Nerlich J.; Tang Y.; Franke H.; Illes P.; Regulation of P2X7 receptor function of neural progenitor cells in the hippocampal subgranular zone by neuronal activity in the dentate gyrus. Neuropharmacology 2018,140,139-149","journal-title":"Neuropharmacology"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fncel.2013.00197","volume":"7","author":"Del Puerto A.","year":"2013","unstructured":"Del Puerto A.; Wandosell F.; Garrido J.J.; Neuronal and glial purinergic receptors functions in neuron development and brain disease. Front Cell Neurosci 2013,7,197","journal-title":"Front Cell Neurosci"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","volume":"36","author":"Jimenez-Pacheco A.","year":"2016","unstructured":"Jimenez-Pacheco A.; Diaz-Hernandez M.; Arribas-Bl\u00e1zquez M.; Sanz-Rodriguez A.; Olivos-Or\u00e9 L.A.; Artalejo A.R.; Alves M.; Letavic M.; Miras-Portugal M.T.; Conroy R.M.; Delanty N.; Farrell M.A.; O\u2019Brien D.F.; Bhattacharya A.; Engel T.; Henshall D.C.; Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy. J Neurosci 2016,36(22),5920-5932","journal-title":"J Neurosci"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1124\/jpet.112.201954","volume":"345","author":"Carlson S.L.","year":"2013","unstructured":"Carlson S.L.; Kumar S.; Werner D.F.; Comerford C.E.; Morrow A.L.; Ethanol activation of protein kinase A regulates GABAA \u03b11 receptor function and trafficking in cultured cerebral cortical neurons. J Pharmacol Exp Ther 2013,345(2),317-325","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/cdd.2015.55","volume":"22","author":"Mueller M.","year":"2015","unstructured":"Mueller M.; Schoeberlein A.; Zhou J.; Joerger-Messerli M.; Oppliger B.; Reinhart U.; Bordey A.; Surbek D.; Barnea E.R.; Huang Y.; Paidas M.; PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling. Cell Death Differ 2015,22(12),2078-2086","journal-title":"Cell Death Differ"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"9914","DOI":"10.1523\/JNEUROSCI.1603-19.2019","volume":"39","author":"Tiwari M.N.","year":"2019","unstructured":"Tiwari M.N.; Mohan S.; Biala Y.; Yaari Y.; Protein kinase A-mediated suppression of the slow afterhyperpolarizing KCa3. 1 current in temporal lobe epilepsy. J Neurosci 2019,39(50),9914-9926","journal-title":"J Neurosci"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainres.2009.05.066","volume":"1283","author":"Bracey J.M.","year":"2009","unstructured":"Bracey J.M.; Kurz J.E.; Low B.; Churn S.B.; Prolonged seizure activity leads to increased Protein Kinase A activation in the rat pilocarpine model of status epilepticus. Brain Res 2009,1283,167-176","journal-title":"Brain Res"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1535-7511.2008.00256.x","volume":"8","author":"Merlin L.R.","year":"2008","unstructured":"Merlin L.R.; Impact of protein kinase C activation on status epilepticus and epileptogenesis: oh, what a tangled web. Epilepsy Curr 2008,8(4),101-103","journal-title":"Epilepsy Curr"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12264-017-0165-7","volume":"34","author":"Zhu F.","year":"2018","unstructured":"Zhu F.; Kai J.; Chen L.; Wu M.; Dong J.; Wang Q.; Zeng L.H.; Akt inhibitor perifosine prevents epileptogenesis in a rat model of temporal lobe epilepsy. Neurosci Bull 2018,34(2),283-290","journal-title":"Neurosci Bull"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnmol.2014.00028","volume":"7","author":"Takei N.","year":"2014","unstructured":"Takei N.; Nawa H.; mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neurosci 2014,7,28","journal-title":"Front Mol Neurosci"},{"key":"ref=145","first-page":"2275","volume":"8","author":"Kesidou E.","year":"2013","unstructured":"Kesidou E.; Lagoudaki R.; Touloumi O.; Poulatsidou K.N.; Simeonidou C.; Autophagy and neurodegenerative disorders. Neural Regen Res 2013,8(24),2275-2283","journal-title":"Neural Regen Res"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/bcp.12804","volume":"82","author":"Maiese K.","year":"2016","unstructured":"Maiese K.; Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol 2016,82(5),1245-1266","journal-title":"Br J Clin Pharmacol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","volume":"51","author":"Wong M.","year":"2010","unstructured":"Wong M.; Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies. Epilepsia 2010,51(1),27-36","journal-title":"Epilepsia"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jns.2013.05.029","volume":"332","author":"Meng X.F.","year":"2013","unstructured":"Meng X.F.; Yu J.T.; Song J.H.; Chi S.; Tan L.; Role of the mTOR signaling pathway in epilepsy. J Neurol Sci 2013,332(1-2),4-15","journal-title":"J Neurol Sci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.pharep.2014.12.017","volume":"67","author":"Sadowski K.","year":"2015","unstructured":"Sadowski K.; Kotulska-J\u00f3\u017awiak K.; J\u00f3\u017awiak S.; Role of mTOR inhibitors in epilepsy treatment. Pharmacol Rep 2015,67(3),636-646","journal-title":"Pharmacol Rep"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","volume":"48","author":"Holmes G.L.","year":"2007","unstructured":"Holmes G.L.; Stafstrom C.E.; Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia Tuberous Sclerosis Study Group2007,48(4),617-630","journal-title":"Epilepsia"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","volume":"1184","author":"Orlova K.A.","year":"2010","unstructured":"Orlova K.A.; Crino P.B.; The tuberous sclerosis complex. Ann N Y Acad Sci 2010,1184,87-105","journal-title":"Ann N Y Acad Sci"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"a022442","DOI":"10.1101\/cshperspect.a022442","volume":"5","author":"Crino P.B.","year":"2015","unstructured":"Crino P.B.; mTOR signaling in epilepsy: insights from malformations of cortical development. Cold Spring Harb Perspect Med 2015,5(4),a022442","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.braindev.2008.09.013","volume":"31","author":"Napolioni V.","year":"2009","unstructured":"Napolioni V.; Moavero R.; Curatolo P.; Recent advances in neurobiology of tuberous sclerosis complex. Brain Dev 2009,31(2),104-113","journal-title":"Brain Dev"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"Heras-Sandoval D.","year":"2014","unstructured":"Heras-Sandoval D.; P\u00e9rez-Rojas J.M.; Hern\u00e1ndez-Dami\u00e1n J.; Pedraza-Chaverri J.; The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 2014,26(12),2694-2701","journal-title":"Cell Signal"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cbpa.2013.11.008","volume":"168","author":"Abuhagr A.M.","year":"2014","unstructured":"Abuhagr A.M.; Maclea K.S.; Chang E.S.; Mykles D.L.; Mechanistic target of rapamycin (mTOR) signaling genes in decapod crustaceans: cloning and tissue expression of mTOR, Akt, Rheb, and p70 S6 kinase in the green crab, Carcinus maenas, and blackback land crab, Gecarcinus lateralis. Comp Biochem Physiol A Mol Integr Physiol 2014,168,25-39","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.coph.2008.08.004","volume":"8","author":"Yap T.A.","year":"2008","unstructured":"Yap T.A.; Garrett M.D.; Walton M.I.; Raynaud F.; de Bono J.S.; Workman P.; Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr Opin Pharmacol 2008,8(4),393-412","journal-title":"Curr Opin Pharmacol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1586\/ern.13.48","volume":"13","author":"Wong M.","year":"2013","unstructured":"Wong M.; A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials. Expert Rev Neurother 2013,13(6),657-669","journal-title":"Expert Rev Neurother"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","volume":"29","author":"Zeng L.H.","year":"2009","unstructured":"Zeng L.H.; Rensing N.R.; Wong M.; The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 2009,29(21),6964-6972","journal-title":"J Neurosci"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.phrs.2016.03.039","volume":"107","author":"Citraro R.","year":"2016","unstructured":"Citraro R.; Leo A.; Constanti A.; Russo E.; De Sarro G.; mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis. Pharmacol Res 2016,107,333-343","journal-title":"Pharmacol Res"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pediatrneurol.2016.09.016","volume":"66","author":"Vogel K.R.","year":"2017","unstructured":"Vogel K.R.; Ainslie G.R.; Schmidt M.A.; Wisor J.P.; Gibson K.M.; mTOR inhibition mitigates molecular and biochemical alterations of vigabatrin-induced visual field toxicity in mice. Pediatr Neurol 2017,66,44-52.e1","journal-title":"Pediatr Neurol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12031-017-0897-x","volume":"61","author":"Chi X.","year":"2017","unstructured":"Chi X.; Huang C.; Li R.; Wang W.; Wu M.; Li J.; Zhou D.; Inhibition of mTOR pathway by rapamycin decreases P-glycoprotein expression and spontaneous seizures in pharmacoresistant epilepsy. J Mol Neurosci 2017,61(4),553-562","journal-title":"J Mol Neurosci"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00406-016-0703-8","volume":"267","author":"Schneider M.","year":"2017","unstructured":"Schneider M.; de Vries P.J.; Sch\u00f6nig K.; R\u00f6\u00dfner V.; Waltereit R.; mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus. Eur Arch Psychiatry Clin Neurosci 2017,267(5),455-463","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.seizure.2010.12.005","volume":"20","author":"Li G.","year":"2011","unstructured":"Li G.; Bauer S.; Nowak M.; Norwood B.; Tackenberg B.; Rosenow F.; Knake S.; Oertel W.H.; Hamer H.M.; Cytokines and epilepsy. Seizure 2011,20(3),249-256","journal-title":"Seizure"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"901902","DOI":"10.1155\/2014\/901902","volume":"2014","author":"Shimada T.","year":"2014","unstructured":"Shimada T.; Takemiya T.; Sugiura H.; Yamagata K.; Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators Inflamm 2014,2014,901902","journal-title":"Mediators Inflamm"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.eplepsyres.2017.07.016","volume":"136","author":"Cerri C.","year":"2017","unstructured":"Cerri C.; Caleo M.; Bozzi Y.; Chemokines as new inflammatory players in the pathogenesis of epilepsy. Epilepsy Res 2017,136,77-83","journal-title":"Epilepsy Res"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.mito.2010.05.014","volume":"10","author":"Witte M.E.","year":"2010","unstructured":"Witte M.E.; Geurts J.J.; de Vries H.E.; van der Valk P.; van Horssen J.; Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 2010,10(5),411-418","journal-title":"Mitochondrion"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/1073858410371379","volume":"16","author":"Wee Yong V.","year":"2010","unstructured":"Wee Yong V.; Inflammation in neurological disorders: a help or a hindrance? Neuroscientist 2010,16(4),408-420","journal-title":"Neuroscientist"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2017.08.009","volume":"298","author":"McElroy P.B.","year":"2017","unstructured":"McElroy P.B.; Liang L.P.; Day B.J.; Patel M.; Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation. Exp Neurol 2017,298(Pt A),13-22","journal-title":"Exp Neurol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12974-014-0212-5","volume":"11","author":"Meng X.F.","year":"2014","unstructured":"Meng X.F.; Tan L.; Tan M.S.; Jiang T.; Tan C.C.; Li M.M.; Wang H.F.; Yu J.T.; Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus. J Neuroinflammation 2014,11,212","journal-title":"J Neuroinflammation"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.expneurol.2007.01.019","volume":"205","author":"Zhang X.M.","year":"2007","unstructured":"Zhang X.M.; Duan R.S.; Chen Z.; Quezada H.C.; Mix E.; Winblad B.; Zhu J.; IL-18 deficiency aggravates kainic acid-induced hippocampal neurodegeneration in C57BL\/6 mice due to an overcompensation by IL-12. Exp Neurol 2007,205(1),64-73","journal-title":"Exp Neurol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.bbi.2011.03.018","volume":"25","author":"Vezzani A.","year":"2011","unstructured":"Vezzani A.; Maroso M.; Balosso S.; Sanchez M.A.; Bartfai T.; IL-1 receptor\/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 2011,25(7),1281-1289","journal-title":"Brain Behav Immun"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.11.010","volume":"326","author":"Thawkar B.S.","year":"2019","unstructured":"Thawkar B.S.; Kaur G.; Inhibitors of NF-\u03baB and P2X7\/NLRP3\/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer\u2019s disease. J Neuroimmunol 2019,326,62-74","journal-title":"J Neuroimmunol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","volume":"67","author":"Wang S.","year":"2019","unstructured":"Wang S.; Yuan Y.H.; Chen N.H.; Wang H.B.; The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease. Int Immunopharmacol 2019,67,458-464","journal-title":"Int Immunopharmacol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"9171","DOI":"10.1038\/s41598-019-45598-x","volume":"9","author":"Vidmar L.","year":"2019","unstructured":"Vidmar L.; Maver A.; Drulovi\u0107 J.; Sep\u010di\u0107 J.; Novakovi\u0107 I.; Risti\u010d S.; \u0160ega S.; Peterlin B.; Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes. Sci Rep 2019,9(1),9171","journal-title":"Sci Rep"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12974-019-1414-7","volume":"16","author":"Gimenes A.D.","year":"2019","unstructured":"Gimenes A.D.; Andrade B.F.D.; Pinotti J.V.P.; Oliani S.M.; Galvis-Alonso O.Y.; Gil C.D.; Annexin A1-derived peptide Ac in a pilocarpine-induced status epilepticus model: anti-inflammatory and neuroprotective effects. J Neuroinflammation 2019,16(1),32","journal-title":"J Neuroinflammation"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.yebeh.2017.03.019","volume":"72","author":"Azim M.S.","year":"2017","unstructured":"Azim M.S.; Agarwal N.B.; Vohora D.; Effects of agomelatine on pentylenetetrazole-induced kindling, kindling-associated oxidative stress, and behavioral despair in mice and modulation of its actions by luzindole and 1-(m-chlorophenyl) piperazine. Epilepsy Behav 2017,72,140-144","journal-title":"Epilepsy Behav"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1111\/febs.12446","volume":"280","author":"Adada M.","year":"2013","unstructured":"Adada M.; Canals D.; Hannun Y.A.; Obeid L.M.; Sphingosine-1-phosphate receptor 2. FEBS J 2013,280(24),6354-6366","journal-title":"FEBS J"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.pharmthera.2011.08.004","volume":"132","author":"Edmonds Y.","year":"2011","unstructured":"Edmonds Y.; Milstien S.; Spiegel S.; Development of small-molecule inhibitors of sphingosine-1-phosphate signaling. Pharmacol Ther 2011,132(3),352-360","journal-title":"Pharmacol Ther"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-016-0303-x","volume":"4","author":"Willems L.M.","year":"2016","unstructured":"Willems L.M.; Zahn N.; Ferreir\u00f3s N.; Scholich K.; Maggio N.; Deller T.; Vlachos A.; Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy. Acta Neuropathol Commun 2016,4,28","journal-title":"Acta Neuropathol Commun"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","volume":"113","author":"O\u2019Sullivan S.","year":"2017","unstructured":"O\u2019Sullivan S.; Dev K.K.; Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases. Neuropharmacology 2017,113(Pt B),597-607","journal-title":"Neuropharmacology"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12974-017-0922-6","volume":"14","author":"Cipriani R.","year":"2017","unstructured":"Cipriani R.; Chara J.C.; Rodr\u00edguez-Antig\u00fcedad A.; Matute C.; Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury. J Neuroinflammation 2017,14(1),147","journal-title":"J Neuroinflammation"},{"key":"ref=182","first-page":"308","volume":"35","author":"Dong Y.Y.","year":"2019","unstructured":"Dong Y.Y.; Wang L.; Chu X.; Cui S.; Kong Q.X.; [Altered expressions of SphK1 and S1PR2 in hippocampus of epileptic rats]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2019,35(4),308-311","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R","volume":"10","author":"Swann J.W.","year":"2000","unstructured":"Swann J.W.; Al-Noori S.; Jiang M.; Lee C.L.; Spine loss and other dendritic abnormalities in epilepsy. Hippocampus 2000,10(5),617-625","journal-title":"Hippocampus"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuroscience.2012.03.048","volume":"251","author":"Wong M.","year":"2013","unstructured":"Wong M.; Guo D.; Dendritic spine pathology in epilepsy: cause or consequence? Neuroscience 2013,251,141-150","journal-title":"Neuroscience"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ni.2730","volume":"14","author":"Garris C.S.","year":"2013","unstructured":"Garris C.S.; Wu L.; Acharya S.; Arac A.; Blaho V.A.; Huang Y.; Moon B.S.; Axtell R.C.; Ho P.P.; Steinberg G.K.; Lewis D.B.; Sobel R.A.; Han D.K.; Steinman L.; Snyder M.P.; Hla T.; Han M.H.; Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol 2013,14(11),1166-1172","journal-title":"Nat Immunol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"106436","DOI":"10.1016\/j.prostaglandins.2020.106436","volume":"149","author":"Raza Z.","year":"2020","unstructured":"Raza Z.; Saleem U.; Naureen Z.; Sphingosine 1-phosphate signaling in ischemia and reperfusion injury. Prostaglandins Other Lipid Mediat 2020,149,106436","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2174\/1871527315666161104163031","volume":"16","author":"Leo A.","year":"2017","unstructured":"Leo A.; Citraro R.; Marra R.; Palma E.; Paola E.D.D.; Constanti A.; De Sarro G.; Russo E.; The sphingosine 1-phosphate signaling pathway in epilepsy: a possible role for the immunomodulator drug fingolimod in epilepsy treatment. CNS Neurol Disord Drug Targets 2017,16(3),311-325","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bcpt.12973","volume":"123","author":"Gao F.","year":"2018","unstructured":"Gao F.; Gao Y.; Meng F.; Yang C.; Fu J.; Li Y.; The sphingosine 1-phosphate analogue FTY720 alleviates seizure-induced overexpression of p-glycoprotein in rat hippocampus. Basic Clin Pharmacol Toxicol 2018,123(1),14-20","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fnins.2018.00084","volume":"12","author":"Diotel N.","year":"2018","unstructured":"Diotel N.; Charlier T.D.; Lefebvre d\u2019Hellencourt C.; Couret D.; Trudeau V.L.; Nicolau J.C.; Meilhac O.; Kah O.; Pellegrini E.; Steroid transport, local synthesis, and signaling within the brain: roles in neurogenesis, neuroprotection, and sexual behaviors. Front Neurosci 2018,12,84","journal-title":"Front Neurosci"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fphar.2018.00354","volume":"9","author":"Grube M.","year":"2018","unstructured":"Grube M.; Hagen P.; Jedlitschky G.; Neurosteroid transport in the brain: role of ABC and SLC transporters. Front Pharmacol 2018,9,354","journal-title":"Front Pharmacol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"100788","DOI":"10.1016\/j.yfrne.2019.100788","volume":"55","author":"Yilmaz C.","year":"2019","unstructured":"Yilmaz C.; Karali K.; Fodelianaki G.; Gravanis A.; Chavakis T.; Charalampopoulos I.; Alexaki V.I.; Neurosteroids as regulators of neuroinflammation. Front Neuroendocrinol 2019,55,100788","journal-title":"Front Neuroendocrinol"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fendo.2019.00169","volume":"10","author":"Ratner M.H.","year":"2019","unstructured":"Ratner M.H.; Kumaresan V.; Farb D.H.; Neurosteroid actions in memory and neurologic\/neuropsychiatric disorders. Front Endocrinol (Lausanne) 2019,10,169","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0920-1211(03)00042-1","volume":"54","author":"Grosso S.","year":"2003","unstructured":"Grosso S.; Luisi S.; Mostardini R.; Farnetani M.; Cobellis L.; Morgese G.; Balestri P.; Petraglia F.; Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children. Epilepsy Res 2003,54(1),29-34","journal-title":"Epilepsy Res"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1528-1167.2010.02627.x","volume":"51","author":"Murashima Y.L.","year":"2010","unstructured":"Murashima Y.L.; Yoshii M.; New therapeutic approaches for epilepsies, focusing on reorganization of the GABAA receptor subunits by neurosteroids. Epilepsia 2010,51(Suppl. 3),131-134","journal-title":"Epilepsia"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nbd.2014.06.010","volume":"72","author":"Reddy D.S.","year":"2014","unstructured":"Reddy D.S.; Neurosteroids and their role in sex-specific epilepsies. Neurobiol Dis 2014,72(Pt B),198-209","journal-title":"Neurobiol Dis"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fendo.2011.00038","volume":"2","author":"Reddy D.S.","year":"2011","unstructured":"Reddy D.S.; Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy. Front Endocrinol (Lausanne) 2011,2,38","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/jne.12063","volume":"25","author":"Biagini G.","year":"2013","unstructured":"Biagini G.; Rustichelli C.; Curia G.; Vinet J.; Lucchi C.; Pugnaghi M.; Meletti S.; Neurosteroids and epileptogenesis. J Neuroendocrinol 2013,25(11),980-990","journal-title":"J Neuroendocrinol"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40501-018-0159-8","volume":"5","author":"Perkins E.C.","year":"2018","unstructured":"Perkins E.C.; Newport D.J.; Neurosteroids in the pathophysiology and treatment of mood and anxiety disorders. Curr Treat Options Psychiatry 2018,5,377-400","journal-title":"Curr Treat Options Psychiatry"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/NRL.0000000000000167","volume":"23","author":"Valencia-Sanchez C.","year":"2018","unstructured":"Valencia-Sanchez C.; Crepeau A.Z.; Hoerth M.T.; Butler K.A.; Almader-Douglas D.; Wingerchuk D.M.; O\u2019Carroll C.B.; Is adjunctive progesterone effective in reducing seizure frequency in patients with intractable catamenial epilepsy? A critically appraised topic. Neurologist 2018,23(3),108-112","journal-title":"Neurologist"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bja.2020.01.013","volume":"124","author":"Tesic V.","year":"2020","unstructured":"Tesic V.; Joksimovic S.M.; Quillinan N.; Krishnan K.; Covey D.F.; Todorovic S.M.; Jevtovic-Todorovic V.; Neuroactive steroids alphaxalone and CDNC24 are effective hypnotics and potentiators of GABA currents, but are not neurotoxic to the developing rat brain. Br J Anaesth 2020,124(5),603-613","journal-title":"Br J Anaesth"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.4103\/1673-5374.215240","volume":"12","author":"Hern\u00e1ndez C.C.","year":"2017","unstructured":"Hern\u00e1ndez C.C.; Burgos C.F.; Gajardo A.H.; Silva-Grecchi T.; Gavilan J.; Toledo J.R.; Fuentealba J.; Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor. Neural Regen Res 2017,12(9),1381-1389","journal-title":"Neural Regen Res"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"112978","DOI":"10.1016\/j.expneurol.2019.112978","volume":"320","author":"Habib P.","year":"2019","unstructured":"Habib P.; Stamm A.S.; Zeyen T.; Noristani R.; Slowik A.; Beyer C.; Wilhelm T.; Huber M.; Komnig D.; Schulz J.B.; Reich A.; EPO regulates neuroprotective Transmembrane BAX Inhibitor-1 Motif-containing (TMBIM) family members GRINA and FAIM2 after cerebral ischemia-reperfusion injury. Exp Neurol 2019,320,112978","journal-title":"Exp Neurol"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3109\/00207454.2013.878935","volume":"124","author":"Bah\u00e7ekap\u0131l\u0131 N.","year":"2014","unstructured":"Bah\u00e7ekap\u0131l\u0131 N.; Akg\u00fcn-Dar K.; Albeniz I.; Kapucu A.; Kandil A.; Ya\u011f\u0131z O.; \u00dcz\u00fcm G.; Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures. Int J Neurosci 2014,124(10),762-770","journal-title":"Int J Neurosci"},{"key":"ref=204","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuroscience.2019.04.013","volume":"439","author":"Roseti C.","year":"2020","unstructured":"Roseti C.; Cifelli P.; Ruffolo G.; Barbieri E.; Guescini M.; Esposito V.; Palma E.; Erythropoietin increases GABAA currents in human cortex from TLE patients Neuroscience 2020,439,153-162","journal-title":"Neuroscience"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.micinf.2011.10.005","volume":"14","author":"Nairz M.","year":"2012","unstructured":"Nairz M.; Sonnweber T.; Schroll A.; Theurl I.; Weiss G.; The pleiotropic effects of erythropoietin in infection and inflammation. Microbes Infect 2012,14(3),238-246","journal-title":"Microbes Infect"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2119\/molmed.2015.00192","volume":"21","author":"Ott C.","year":"2015","unstructured":"Ott C.; Martens H.; Hassouna I.; Oliveira B.; Erck C.; Zafeiriou M.P.; Peteri U.K.; Hesse D.; Gerhart S.; Altas B.; Kolbow T.; Stadler H.; Kawabe H.; Zimmermann W.H.; Nave K.A.; Schulz-Schaeffer W.; Jahn O.; Ehrenreich H.; Widespread expression of erythropoietin receptor in brain and its induction by injury. Mol Med 2015,21(1),803-815","journal-title":"Mol Med"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2741\/4295","volume":"19","author":"Castaneda-Arellano R.","year":"2014","unstructured":"Castaneda-Arellano R.; Beas-Zarate C.; Feria-Velasco A.I.; Bitar-Alatorre E.W.; Rivera-Cervantes M.C.; From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin. Front Biosci 2014,19,1445-1455","journal-title":"Front Biosci"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11064-017-2443-1","volume":"43","author":"Li Q.","year":"2018","unstructured":"Li Q.; Han Y.; Du J.; Jin H.; Zhang J.; Niu M.; Qin J.; Recombinant human erythropoietin protects against hippocampal damage in developing rats with seizures by modulating autophagy via the S6 protein in a time-dependent manner. Neurochem Res 2018,43(2),465-476","journal-title":"Neurochem Res"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1074\/jbc.M109.040022","volume":"285","author":"Kaspar J.W.","year":"2010","unstructured":"Kaspar J.W.; Jaiswal A.K.; Antioxidant-induced phosphorylation of tyrosine 486 leads to rapid nuclear export of Bach1 that allows Nrf2 to bind to the antioxidant response element and activate defensive gene expression. J Biol Chem 2010,285(1),153-162","journal-title":"J Biol Chem"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1096\/fj.10-171553","volume":"25","author":"Kaspar J.W.","year":"2011","unstructured":"Kaspar J.W.; Jaiswal A.K.; Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB J 2011,25(3),1076-1087","journal-title":"FASEB J"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1242\/jcs.097295","volume":"125","author":"Kaspar J.W.","year":"2012","unstructured":"Kaspar J.W.; Niture S.K.; Jaiswal A.K.; Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression. J Cell Sci 2012,125(Pt 4),1027-1038","journal-title":"J Cell Sci"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1124\/pr.110.004333","volume":"64","author":"Ma Q.","year":"2012","unstructured":"Ma Q.; He X.; Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev 2012,64(4),1055-1081","journal-title":"Pharmacol Rev"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Ma Q.","year":"2013","unstructured":"Ma Q.; Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 2013,53,401-426","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"878030","DOI":"10.1155\/2012\/878030","volume":"2012","author":"Petri S.","year":"2012","unstructured":"Petri S.; K\u00f6rner S.; Kiaei M.; Nrf2\/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int 2012,2012,878030","journal-title":"Neurol Res Int"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuropharm.2013.11.004","volume":"79","author":"Sandberg M.","year":"2014","unstructured":"Sandberg M.; Patil J.; D\u2019Angelo B.; Weber S.G.; Mallard C.; NRF2-regulation in brain health and disease: implication of cerebral inflammation. Neuropharmacology 2014,79,298-306","journal-title":"Neuropharmacology"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"38","DOI":"10.20455\/ros.2016.807","volume":"1","author":"Kovac S.","year":"2016","unstructured":"Kovac S.; Dinkova-Kostova A.T.; Abramov A.Y.; The role of reactive oxygen species in epilepsy. React Oxyg Species (Apex) 2016,1,38-52","journal-title":"React Oxyg Species (Apex)"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000486768","volume":"45","author":"Shi Y.","year":"2018","unstructured":"Shi Y.; Miao W.; Teng J.; Zhang L.; Ginsenoside Rb1 protects the brain from damage induced by epileptic seizure via Nrf2\/ARE signaling. Cell Physiol Biochem 2018,45(1),212-225","journal-title":"Cell Physiol Biochem"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s11064-018-2496-9","volume":"43","author":"Jin M.","year":"2018","unstructured":"Jin M.; He Q.; Zhang S.; Cui Y.; Han L.; Liu K.; Gastrodin suppresses pentylenetetrazole-induced seizures progression by modulating oxidative stress in zebrafish. Neurochem Res 2018,43(4),904-917","journal-title":"Neurochem Res"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"18348","DOI":"10.3390\/ijms160818348","volume":"16","author":"Carmona-Aparicio L.","year":"2015","unstructured":"Carmona-Aparicio L.; P\u00e9rez-Cruz C.; Zavala-Tecuapetla C.; Granados-Rojas L.; Rivera-Espinosa L.; Montesinos-Correa H.; Hern\u00e1ndez-Dami\u00e1n J.; Pedraza-Chaverri J.; Sampieri A.; Coballase-Urrutia E.; C\u00e1rdenas-Rodr\u00edguez N.; Overview of Nrf2 as therapeutic target in epilepsy. Int J Mol Sci 2015,16(8),18348-18367","journal-title":"Int J Mol Sci"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bph.12133","volume":"169","author":"Chen X.","year":"2013","unstructured":"Chen X.; Liu J.; Chen S.Y.; Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neural crest cells by the induction of Nrf2-mediated antioxidant response. Br J Pharmacol 2013,169(2),437-448","journal-title":"Br J Pharmacol"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"Singh S.","year":"2020","unstructured":"Singh S.; Singh T.G.; Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: An mechanistic approach. Curr Neuropharmacol 2020,18,10-35","journal-title":"Curr Neuropharmacol"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"116867","DOI":"10.1016\/j.lfs.2019.116867","volume":"236","author":"Iqubal A.","year":"2019","unstructured":"Iqubal A.; Sharma S.; Najmi A.K.; Syed M.A.; Ali J.; Alam M.M.; Haque S.E.; Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF- \u03baB. Life Sci 2019,236,116867","journal-title":"Life Sci"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1074\/jbc.M209241200","volume":"278","author":"Tischkau S.A.","year":"2003","unstructured":"Tischkau S.A.; Mitchell J.W.; Tyan S.H.; Buchanan G.F.; Gillette M.U.; Ca\/cAMP Response Element-Binding protein (CREB)-dependent activation of Per1 is required for light-induced signaling in the suprachiasmatic nucleus circadian clock. J Biol Chem 2003,278(2),718-723","journal-title":"J Biol Chem"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1093\/cercor\/bhp004","volume":"19","author":"Jancic D.","year":"2009","unstructured":"Jancic D.; Lopez de Armentia M.; Valor L.M.; Olivares R.; Barco A.; Inhibition of cAMP response element-binding protein reduces neuronal excitability and plasticity, and triggers neurodegeneration. Cereb Cortex 2009,19(11),2535-2547","journal-title":"Cereb Cortex"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.eplepsyres.2017.11.004","volume":"140","author":"Wu G.","year":"2018","unstructured":"Wu G.; Yu J.; Wang L.; Ren S.; Zhang Y.; PKC\/CREB pathway mediates the expressions of GABA receptor subunits in cultured hippocampal neurons after low-Mg solution treatment. Epilepsy Res 2018,140,155-161","journal-title":"Epilepsy Res"},{"key":"ref=226","first-page":"949","volume":"38","author":"Lou Y.","year":"2007","unstructured":"Lou Y.; Wang W.P.; Li P.; Duan R.S.; Pei L.; Interrelationship between change of cAMP responsive element binding protein (CREB) or N-methyl-D-aspartate receptor (NR1) expressing in hippocampus and impairment of learning and memory after epilepsy. Sichuan Da Xue Xue Bao Yi Xue Ban 2007,38(6),949-953","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/1028415X.2018.1478653","volume":"23","author":"Sharma P.","year":"2020","unstructured":"Sharma P.; Sharma S.; Singh D.; Apigenin reverses behavioural impairments and cognitive decline in kindled mice via CREB-BDNF upregulation in the hippocampus. Nutr Neurosci 2020,23(2),118-127","journal-title":"Nutr Neurosci"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/emm.2003.48","volume":"35","author":"Park S.A.","year":"2003","unstructured":"Park S.A.; Kim T.S.; Choi K.S.; Park H.J.; Heo K.; Lee B.I.; Chronic activation of CREB and p90RSK in human epileptic hippocampus. Exp Mol Med 2003,35(5),365-370","journal-title":"Exp Mol Med"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/epi.12036","volume":"53","author":"Grabenstatter H.L.","year":"2012","unstructured":"Grabenstatter H.L.; Russek S.J.; Brooks-Kayal A.R.; Molecular pathways controlling inhibitory receptor expression. Epilepsia 2012,53(Suppl. 9),71-78","journal-title":"Epilepsia"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.nbd.2011.08.009","volume":"45","author":"Zhu X.","year":"2012","unstructured":"Zhu X.; Han X.; Blendy J.A.; Porter B.E.; Decreased CREB levels suppress epilepsy. Neurobiol Dis 2012,45(1),253-263","journal-title":"Neurobiol Dis"},{"key":"ref=231","first-page":"1297","volume":"7","author":"Guo J.","year":"2014","unstructured":"Guo J.; Wang H.; Wang Q.; Chen Y.; Chen S.; Expression of p-CREB and activity-dependent miR-132 in temporal lobe epilepsy. Int J Clin Exp Med 2014,7(5),1297-1306","journal-title":"Int J Clin Exp Med"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/epi.13211","volume":"56","author":"Zhu X.","year":"2015","unstructured":"Zhu X.; Dubey D.; Bermudez C.; Porter B.E.; Suppressing cAMP response element-binding protein transcription shortens the duration of status epilepticus and decreases the number of spontaneous seizures in the pilocarpine model of epilepsy. Epilepsia 2015,56(12),1870-1878","journal-title":"Epilepsia"},{"key":"ref=233","first-page":"398","volume":"7","author":"Yu J.","year":"2017","unstructured":"Yu J.; Liu Z.; Wang L.; Wu G.; Wu M.; Increased GABA (A) Receptors alpha1, gamma2, delta Subunits might be Associated with the Activation of the CREB Gene in Low Mg Model of Epilepsy. Neuropsychiatry (London) 2017,7,398-405","journal-title":"Neuropsychiatry (London)"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2174\/15672050113109990007","volume":"10","author":"Zhang X.M.","year":"2013","unstructured":"Zhang X.M.; Zheng X.Y.; Sharkawi S.S.; Ruan Y.; Amir N.; Azimullah S.; Hasan M.Y.; Zhu J.; Adem A.; Possible protecting role of TNF-\u03b1 in kainic acid-induced neurotoxicity via down-regulation of NF\u03baB signaling pathway. Curr Alzheimer Res 2013,10(6),660-669","journal-title":"Curr Alzheimer Res"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/epi.12030","volume":"53","author":"Roopra A.","year":"2012","unstructured":"Roopra A.; Dingledine R.; Hsieh J.; Epigenetics and epilepsy. Epilepsia 2012,53(Suppl. 9),2-10","journal-title":"Epilepsia"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.conb.2017.12.008","volume":"48","author":"Hwang J.Y.","year":"2018","unstructured":"Hwang J.Y.; Zukin R.S.; REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurobiol 2018,48,193-200","journal-title":"Curr Opin Neurobiol"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"13235","DOI":"10.1523\/JNEUROSCI.1981-10.2010","volume":"30","author":"Mucha M.","year":"2010","unstructured":"Mucha M.; Ooi L.; Linley J.E.; Mordaka P.; Dalle C.; Robertson B.; Gamper N.; Wood I.C.; Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. J Neurosci 2010,30(40),13235-13245","journal-title":"J Neurosci"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"e01267","DOI":"10.7554\/eLife.01267","volume":"3","author":"McClelland S.","year":"2014","unstructured":"McClelland S.; Brennan G.P.; Dub\u00e9 C.; Rajpara S.; Iyer S.; Richichi C.; Bernard C.; Baram T.Z.; The transcription factor NRSF contributes to epileptogenesis by selective repression of a subset of target genes. eLife 2014,3,e01267","journal-title":"eLife"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2015.12.001","volume":"56","author":"Soysal H.","year":"2016","unstructured":"Soysal H.; Do\u011fan Z.; Kam\u0131\u015fl\u0131 \u00d6.; Effects of phenytoin and lamotrigine treatment on serum BDNF levels in offsprings of epileptic rats. Neuropeptides 2016,56,1-8","journal-title":"Neuropeptides"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12906-018-2330-6","volume":"18","author":"Sharma A.","year":"2018","unstructured":"Sharma A.; Kaur G.; Tinospora cordifolia as a potential neuroregenerative candidate against glutamate induced excitotoxicity: an in vitro perspective. BMC Complement Altern Med 2018,18(1),268","journal-title":"BMC Complement Altern Med"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12640-018-9971-6","volume":"35","author":"Nagib M.M.","year":"2019","unstructured":"Nagib M.M.; Tadros M.G.; Rahmo R.M.; Sabri N.A.; Khalifa A.E.; Masoud S.I.; Ameliorative effects of \u03b1-tocopherol and\/or coenzyme Q10 on phenytoin-induced cognitive impairment in rats: role of VEGF and BDNF-TrkB-CREB pathway. Neurotox Res 2019,35(2),451-462","journal-title":"Neurotox Res"},{"key":"ref=242","first-page":"3698","volume":"55","author":"Mart\u00ednez-Levy G.A.","year":"2018","unstructured":"Mart\u00ednez-Levy G.A.; Rocha L.; Rodr\u00edguez-Pineda F.; Alonso-Vanegas M.A.; Nani A.; Buentello-Garc\u00eda R.M.; Briones-Velasco M.; San-Juan D.; Cienfuegos J.; Cruz-Fuentes C.S.; Increased expression of brain-derived neurotrophic factor transcripts I and VI, cAMP response element binding, and glucocorticoid receptor in the cortex of patients with temporal lobe epilepsy. Mol Neurobiol 2018,55(5),3698-3708","journal-title":"Mol Neurobiol"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.npep.2018.09.005","volume":"72","author":"Iughetti L.","year":"2018","unstructured":"Iughetti L.; Lucaccioni L.; Fugetto F.; Predieri B.; Berardi A.; Ferrari F.; Brain-derived neurotrophic factor and epilepsy: a systematic review. Neuropeptides 2018,72,23-29","journal-title":"Neuropeptides"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","volume":"220","author":"Lu B.","year":"2014","unstructured":"Lu B.; Nagappan G.; Lu Y.; BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol 2014,220,223-250","journal-title":"Handb Exp Pharmacol"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1038\/sj.emboj.7601911","volume":"26","author":"Nateri A.S.","year":"2007","unstructured":"Nateri A.S.; Raivich G.; Gebhardt C.; Da Costa C.; Naumann H.; Vreugdenhil M.; Makwana M.; Brandner S.; Adams R.H.; Jefferys J.G.; Kann O.; Behrens A.; ERK activation causes epilepsy by stimulating NMDA receptor activity. EMBO J 2007,26(23),4891-4901","journal-title":"EMBO J"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jnr.24196","volume":"96","author":"de Almeida A.A.","year":"2018","unstructured":"de Almeida A.A.; Gomes da Silva S.; Lopim G.M.; Vannucci Campos D.; Fernandes J.; Cabral F.R.; Arida R.M.; Physical exercise alters the activation of downstream proteins related to BDNF-TrkB signaling in male Wistar rats with epilepsy. J Neurosci Res 2018,96(5),911-920","journal-title":"J Neurosci Res"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2010.03.003","volume":"224","author":"Li Y.","year":"2010","unstructured":"Li Y.; Peng Z.; Xiao B.; Houser C.R.; Activation of ERK by spontaneous seizures in neural progenitors of the dentate gyrus in a mouse model of epilepsy. Exp Neurol 2010,224(1),133-145","journal-title":"Exp Neurol"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.euroneuro.2017.12.027","volume":"28","author":"Sivakova N.","year":"2018","unstructured":"Sivakova N.; Lipatova L.; Serebryanaya N.; The role of neuroinflammation in pathogenesis of epilepsy and the possibility of neuroimmunomodulation. Eur Neuropsychopharmacol 2018,28,S9-S10","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep38593","volume":"6","author":"Yang F.","year":"2016","unstructured":"Yang F.; Sun X.; Ding Y.; Ma H.; Yang T.O.; Ma Y.; Jiang W.; Astrocytic acid-sensing ion channel 1a contributes to the development of chronic epileptogenesis. Sci Rep 2016,6,1-14","journal-title":"Sci Rep"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s12035-015-9130-5","volume":"53","author":"Wu H.","year":"2016","unstructured":"Wu H.; Wang C.; Liu B.; Li H.; Zhang Y.; Dong S.; Gao G.; Zhang H.; Altered expression pattern of acid-sensing ion channel isoforms in piriform cortex after seizures. Mol Neurobiol 2016,53(3),1782-1793","journal-title":"Mol Neurobiol"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1152\/physiol.00016.2017","volume":"32","author":"Sun S.","year":"2017","unstructured":"Sun S.; Li H.; Chen J.; Qian Q.; Lactic acid: no longer an inert and end-product of glycolysis. Physiology (Bethesda) 2017,32(6),453-463","journal-title":"Physiology (Bethesda)"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5772\/66699","author":"Schurr A.","year":"2017","unstructured":"Schurr A.;  Lactate, not pyruvate, is the end product of glucose metabolism via glycolysis 2017,21-35","journal-title":"Lactate, not pyruvate, is the end product of glucose metabolism via glycolysis"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11064-018-2540-9","volume":"43","author":"Cao Q.","year":"2018","unstructured":"Cao Q.; Xiao Z.M.; Wang X.; Weng C.; Ding M.; Zhu F.; Lu Z.N.; Inhibition of acid sensing ion channel 3 aggravates seizures by regulating NMDAR function. Neurochem Res 2018,43(6),1227-1241","journal-title":"Neurochem Res"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"3728096","DOI":"10.1155\/2017\/3728096","volume":"2017","author":"Ortega-Ram\u00edrez A.","year":"2017","unstructured":"Ortega-Ram\u00edrez A.; Vega R.; Soto E.; Acid-sensing ion channels as potential therapeutic targets in neurodegeneration and neuroinflammation. Mediators Inflamm 2017,2017,3728096","journal-title":"Mediators Inflamm"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.devcel.2018.02.014","volume":"44","author":"Fitzwalter B.E.","year":"2018","unstructured":"Fitzwalter B.E.; Towers C.G.; Sullivan K.D.; Andrysik Z.; Hoh M.; Ludwig M.; O\u2019Prey J.; Ryan K.M.; Espinosa J.M.; Morgan M.J.; Thorburn A.; Autophagy inhibition mediates apoptosis sensitization in cancer therapy by relieving FOXO3a turnover. Dev Cell 2018,44(5),555-565.e3","journal-title":"Dev Cell"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.eplepsyres.2014.01.003","volume":"108","author":"Kim Y.S.","year":"2014","unstructured":"Kim Y.S.; Choi M.Y.; Lee D.H.; Jeon B.T.; Roh G.S.; Kim H.J.; Kang S.S.; Cho G.J.; Choi W.S.; Decreased interaction between FoxO3a and Akt correlates with seizure-induced neuronal death. Epilepsy Res 2014,108(3),367-378","journal-title":"Epilepsy Res"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/jnc.12133","volume":"124","author":"Caballero-Caballero A.","year":"2013","unstructured":"Caballero-Caballero A.; Engel T.; Martinez-Villarreal J.; Sanz-Rodriguez A.; Chang P.; Dunleavy M.; Mooney C.M.; Jimenez-Mateos E.M.; Schindler C.K.; Henshall D.C.; Mitochondrial localization of the forkhead box class O transcription factor FOXO3a in brain. J Neurochem 2013,124(6),749-756","journal-title":"J Neurochem"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s12272-016-0733-9","volume":"39","author":"Park S.H.","year":"2016","unstructured":"Park S.H.; Sim Y.B.; Lee J.K.; Lee J.Y.; Suh H.W.; Characterization of temporal expressions of FOXO and pFOXO proteins in the hippocampus by kainic acid in mice: involvement of NMDA and non-NMDA receptors. Arch Pharm Res 2016,39(5),660-667","journal-title":"Arch Pharm Res"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fncel.2014.00307","volume":"8","author":"de Curtis I.","year":"2014","unstructured":"de Curtis I.; Roles of Rac1 and Rac3 GTPases during the development of cortical and hippocampal GABAergic interneurons. Front Cell Neurosci 2014,8,307","journal-title":"Front Cell Neurosci"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1007\/s12035-015-9406-9","volume":"53","author":"Li J.","year":"2016","unstructured":"Li J.; Mi X.; Chen L.; Jiang G.; Wang N.; Zhang Y.; Deng W.; Wang Z.; Chen G.; Wang X.; Dock3 participate in epileptogenesis through rac1 pathway in animal models. Mol Neurobiol 2016,53(4),2715-2725","journal-title":"Mol Neurobiol"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/cercor\/bhs402","volume":"24","author":"Vaghi V.","year":"2014","unstructured":"Vaghi V.; Pennucci R.; Talpo F.; Corbetta S.; Montinaro V.; Barone C.; Croci L.; Spaiardi P.; Consalez G.G.; Biella G.; de Curtis I.; Rac1 and rac3 GTPases control synergistically the development of cortical and hippocampal GABAergic interneurons. Cereb Cortex 2014,24(5),1247-1258","journal-title":"Cereb Cortex"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1128\/MCB.18.11.6719","volume":"18","author":"Bharti A.","year":"1998","unstructured":"Bharti A.; Kraeft S.K.; Gounder M.; Pandey P.; Jin S.; Yuan Z.M.; Lees-Miller S.P.; Weichselbaum R.; Weaver D.; Chen L.B.; Kufe D.; Kharbanda S.; Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol 1998,18(11),6719-6728","journal-title":"Mol Cell Biol"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"Pasparakis M.","year":"2015","unstructured":"Pasparakis M.; Vandenabeele P.; Necroptosis and its role in inflammation. Nature 2015,517(7534),311-320","journal-title":"Nature"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0169-328X(01)00008-0","volume":"87","author":"Culmsee C.","year":"2001","unstructured":"Culmsee C.; Bondada S.; Mattson M.P.; Hippocampal neurons of mice deficient in DNA-dependent protein kinase exhibit increased vulnerability to DNA damage, oxidative stress and excitotoxicity. Brain Res Mol Brain Res 2001,87(2),257-262","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1523\/JNEUROSCI.3944-06.2007","volume":"27","author":"Song J.","year":"2007","unstructured":"Song J.; Hu J.; Tanouye M.; Seizure suppression by top1 mutations in Drosophila. J Neurosci 2007,27(11),2927-2937","journal-title":"J Neurosci"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.neuroscience.2008.07.024","volume":"156","author":"Song J.","year":"2008","unstructured":"Song J.; Parker L.; Hormozi L.; Tanouye M.A.; DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy. Neuroscience 2008,156(3),722-728","journal-title":"Neuroscience"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"11894","DOI":"10.1073\/pnas.0501434102","volume":"102","author":"Roberts D.S.","year":"2005","unstructured":"Roberts D.S.; Raol Y.H.; Bandyopadhyay S.; Lund I.V.; Budreck E.C.; Passini M.A.; Wolfe J.H.; Brooks-Kayal A.R.; Russek S.J.; Egr3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor \u03b14 subunit expression. Proc Natl Acad Sci USA 2005,102(33),11894-11899","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/nar\/gkg186","volume":"31","author":"Decker E.L.","year":"2003","unstructured":"Decker E.L.; Nehmann N.; Kampen E.; Eibel H.; Zipfel P.F.; Skerka C.; Early Growth Response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res 2003,31(3),911-921","journal-title":"Nucleic Acids Res"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/jnc.13077","volume":"133","author":"Mo J.","year":"2015","unstructured":"Mo J.; Kim C.H.; Lee D.; Sun W.; Lee H.W.; Kim H.; Early growth response 1 (Egr-1) directly regulates GABAA receptor \u03b12, \u03b14, and \u03b8 subunits in the hippocampus. J Neurochem 2015,133(4),489-500","journal-title":"J Neurochem"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00405-014-3479-3","volume":"273","author":"Hu S.S.","year":"2016","unstructured":"Hu S.S.; Mei L.; Chen J.Y.; Huang Z.W.; Wu H.; Expression of immediate-early genes in the dorsal cochlear nucleus in salicylate-induced tinnitus. Eur Arch Otorhinolaryngol 2016,273(2),325-332","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S1734-1140(13)71012-0","volume":"65","author":"Szyndler J.","year":"2013","unstructured":"Szyndler J.; Maciejak P.; Wis\u0142owska-Stanek A.; Lehner M.; P\u0142a\u017anik A.; Changes in the Egr1 and Arc expression in brain structures of pentylenetetrazole-kindled rats. Pharmacol Rep 2013,65(2),368-378","journal-title":"Pharmacol Rep"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.yebeh.2015.12.020","volume":"71","author":"L\u00f3pez-L\u00f3pez D.","year":"2017","unstructured":"L\u00f3pez-L\u00f3pez D.; G\u00f3mez-Nieto R.; Herrero-Turri\u00f3n M.J.; Garc\u00eda-Cairasco N.; S\u00e1nchez-Benito D.; Lude\u00f1a M.D.; L\u00f3pez D.E.; Overexpression of the immediate-early genes Egr1, Egr2, and Egr3 in two strains of rodents susceptible to audiogenic seizures. Epilepsy Behav 2017,71(Pt B),226-237","journal-title":"Epilepsy Behav"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.7717\/peerj.214","volume":"1","author":"Amada N.","year":"2013","unstructured":"Amada N.; Yamasaki Y.; Williams C.M.; Whalley B.J.; Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression. PeerJ 2013,1,e214","journal-title":"PeerJ"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"29431","DOI":"10.1074\/jbc.C600167200","volume":"281","author":"Roberts D.S.","year":"2006","unstructured":"Roberts D.S.; Hu Y.; Lund I.V.; Brooks-Kayal A.R.; Russek S.J.; BDNF-induced synthesis of early growth response factor 3 (EGR3) controls the levels of type a GABA receptor \u03b14 subunits in hippocampal neurons. J Biol Chem 2006,281,29431-29435","journal-title":"J Biol Chem"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1113\/JP275477","volume":"596","author":"Bauer C.K.","year":"2018","unstructured":"Bauer C.K.; Schwarz J.R.; Ether-\u00e0-go-go K channels: effective modulators of neuronal excitability. J Physiol 2018,596(5),769-783","journal-title":"J Physiol"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature12487","volume":"501","author":"Haitin Y.","year":"2013","unstructured":"Haitin Y.; Carlson A.E.; Zagotta W.N.; The structural mechanism of KCNH-channel regulation by the eag domain. Nature 2013,501(7467),444-448","journal-title":"Nature"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1113\/JP275970","volume":"596","author":"Xiao K.","year":"2018","unstructured":"Xiao K.; Sun Z.; Jin X.; Ma W.; Song Y.; Lai S.; Chen Q.; Fan M.; Zhang J.; Yue W.; Huang Z.; ERG3 potassium channel-mediated suppression of neuronal intrinsic excitability and prevention of seizure generation in mice. J Physiol 2018,596(19),4729-4752","journal-title":"J Physiol"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainresbull.2018.06.017","volume":"142","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Fang J.; Feng W.; Sun Q.; Xu J.; Xia Q.; The role of the GLP-1\/GLP-1R signaling pathway in regulating seizure susceptibility in rats. Brain Res Bull 2018,142,47-53","journal-title":"Brain Res Bull"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neuropharm.2017.11.015","volume":"136","author":"Koshal P.","year":"2018","unstructured":"Koshal P.; Jamwal S.; Kumar P.; Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review. Neuropharmacology 2018,136(Pt B),271-279","journal-title":"Neuropharmacology"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.11.021","volume":"65","author":"Anderberg R.H.","year":"2016","unstructured":"Anderberg R.H.; Richard J.E.; Hansson C.; Nissbrandt H.; Bergquist F.; Skibicka K.P.; GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality. Psychoneuroendocrinology 2016,65,54-66","journal-title":"Psychoneuroendocrinology"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"12","DOI":"10.14710\/jbtr.v5i1.3925","volume":"5","author":"Willemsen R.","year":"2019","unstructured":"Willemsen R.; Fragile X syndrome, the search for a targeted treatment. J Biomed and Trans Res 2019,5,12-14","journal-title":"J Biomed and Trans Res"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1469-8749.2002.tb00277.x","volume":"44","author":"Berry-Kravis E.","year":"2002","unstructured":"Berry-Kravis E.; Epilepsy in fragile X syndrome. Dev Med Child Neurol 2002,44(11),724-728","journal-title":"Dev Med Child Neurol"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1535-7511.2009.01309.x","volume":"9","author":"Hagerman P.J.","year":"2009","unstructured":"Hagerman P.J.; Stafstrom C.E.; Origins of epilepsy in fragile X syndrome. Epilepsy Curr 2009,9(4),108-112","journal-title":"Epilepsy Curr"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/nn.3864","volume":"17","author":"Zhang Y.","year":"2014","unstructured":"Zhang Y.; Bonnan A.; Bony G.; Ferezou I.; Pietropaolo S.; Ginger M.; Sans N.; Rossier J.; Oostra B.; LeMasson G.; Frick A.; Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-\/y) mice. Nat Neurosci 2014,17(12),1701-1709","journal-title":"Nat Neurosci"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"10468","DOI":"10.1038\/srep10468","volume":"5","author":"Zhang W.","year":"2015","unstructured":"Zhang W.; Xu C.; Tu H.; Wang Y.; Sun Q.; Hu P.; Hu Y.; Rondard P.; Liu J.; GABAB receptor upregulates fragile X mental retardation protein expression in neurons. Sci Rep 2015,5,10468","journal-title":"Sci Rep"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1073\/pnas.0703015105","volume":"105","author":"Grainger A.","year":"2008","unstructured":"Grainger A.; Difficulties in tracking the long-term global trend in tropical forest area. Proc Natl Acad Sci USA 2008,105(2),818-823","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1212\/WNL.0b013e31824e8efb","volume":"78","author":"Busch R.M.","year":"2012","unstructured":"Busch R.M.; Frazier T.; Chapin J.S.; Hamrahian A.H.; Diehl B.; Alexopoulos A.; Unnwongse K.; Naugle R.I.; Kubu C.S.; Tesar G.E.; Najm I.M.; Role of cortisol in mood and memory in patients with intractable temporal lobe epilepsy. Neurology 2012,78(14),1064-1068","journal-title":"Neurology"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.0013-9580.2005.59704.x","volume":"46","author":"Galimberti C.A.","year":"2005","unstructured":"Galimberti C.A.; Magri F.; Copello F.; Arbasino C.; Cravello L.; Casu M.; Patrone V.; Murialdo G.; Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment. Epilepsia 2005,46(4),517-523","journal-title":"Epilepsia"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.yebeh.2012.09.040","volume":"26","author":"Maguire J.","year":"2013","unstructured":"Maguire J.; Salpekar J.A.; Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy. Epilepsy Behav 2013,26(3),352-362","journal-title":"Epilepsy Behav"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.yhbeh.2012.03.004","volume":"61","author":"Tolmacheva E.A.","year":"2012","unstructured":"Tolmacheva E.A.; Oitzl M.S.; van Luijtelaar G.; Stress, glucocorticoids and absences in a genetic epilepsy model. Horm Behav 2012,61(5),706-710","journal-title":"Horm Behav"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1528-1167.2010.02623.x","volume":"51","author":"Pineda E.","year":"2010","unstructured":"Pineda E.; Shin D.; Sankar R.; Mazarati A.M.; Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms. Epilepsia 2010,51(Suppl. 3),110-114","journal-title":"Epilepsia"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"8152373","DOI":"10.1155\/2018\/8152373","volume":"2018","author":"Gomes B.A.Q.","year":"2018","unstructured":"Gomes B.A.Q.; Silva J.P.B.; Romeiro C.F.R.; Dos Santos S.M.; Rodrigues C.A.; Gon\u00e7alves P.R.; Sakai J.T.; Mendes P.F.S.; Varela E.L.P.; Monteiro M.C.; Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1. Oxid Med Cell Longev 2018,2018,8152373","journal-title":"Oxid Med Cell Longev"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3389\/fnmol.2017.00443","volume":"10","author":"Zhou Y.","year":"2018","unstructured":"Zhou Y.; Wang S.; Li Y.; Yu S.; Zhao Y.; SIRT1\/PGC-1\u03b1 signaling promotes mitochondrial functional recovery and reduces apoptosis after intracerebral hemorrhage in rats. Front Mol Neurosci 2018,10,443","journal-title":"Front Mol Neurosci"},{"key":"ref=294","first-page":"149","volume":"52","author":"Zeng X.X.","year":"2019","unstructured":"Zeng X.X.; Deng J.; Xiang J.; Dong Y.T.; Cao K.; Liu X.H.; Guana Z.Z.; Resveratrol attenuated the increased level of oxidative stress in the brains and the deficit of learning and memory of rats with chronic fluorosis. Fluoride 2019,52,149-160","journal-title":"Fluoride"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.3390\/ijms20143588","volume":"20","author":"Chuang Y.C.","year":"2019","unstructured":"Chuang Y.C.; Chen S.D.; Jou S.B.; Lin T.K.; Chen S.F.; Chen N.C.; Hsu C.Y.; Sirtuin 1 regulates mitochondrial biogenesis and provides an endogenous neuroprotective mechanism against seizure-induced neuronal cell death in the hippocampus following status epilepticus. Int J Mol Sci 2019,20(14),3588","journal-title":"Int J Mol Sci"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4172\/2155-9880.1000216","volume":"3","author":"Mohar D.S.","year":"2012","unstructured":"Mohar D.S.; Malik S.; The sirtuin system: the holy grail of resveratrol? J Clin Exp Cardiolog 2012,3(11),216","journal-title":"J Clin Exp Cardiolog"},{"key":"ref=297","first-page":"528","volume":"33","author":"Chen Y.","year":"2013","unstructured":"Chen Y.; Xie Y.; Wang H.; Chen Y.; SIRT1 expression and activity are up-regulated in the brain tissue of epileptic patients and rat models. Nan Fang Yi Ke Da Xue Xue Bao 2013,33(4),528-532","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3390\/ijms19072118","volume":"19","author":"Maugeri A.","year":"2018","unstructured":"Maugeri A.; Barchitta M.; Mazzone M.G.; Giuliano F.; Basile G.; Agodi A.; Resveratrol modulates SIRT1 and DNMT functions and restores LINE-1 methylation levels in ARPE-19 cells under oxidative stress and inflammation. Int J Mol Sci 2018,19(7),2118","journal-title":"Int J Mol Sci"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/biof.1399","volume":"44","author":"Truong V.L.","year":"2018","unstructured":"Truong V.L.; Jun M.; Jeong W.S.; Role of resveratrol in regulation of cellular defense systems against oxidative stress. Biofactors 2018,44(1),36-49","journal-title":"Biofactors"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2741\/4267","volume":"19","author":"Pall\u00e0s M.","year":"2014","unstructured":"Pall\u00e0s M.; Ortu\u00f1o-Sahag\u00fan D.; Andr\u00e9s-Benito P.; Ponce-Regalado M.D.; Rojas-Mayorqu\u00edn A.E.; Resveratrol in epilepsy: preventive or treatment opportunities? Front Biosci 2014,19,1057-1064","journal-title":"Front Biosci"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/j.1528-1167.2011.03081.x","volume":"52","author":"Musto A.E.","year":"2011","unstructured":"Musto A.E.; Gjorstrup P.; Bazan N.G.; The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia 2011,52(9),1601-1608","journal-title":"Epilepsia"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.semcdb.2011.07.005","volume":"22","author":"Fassio A.","year":"2011","unstructured":"Fassio A.; Raimondi A.; Lignani G.; Benfenati F.; Baldelli P.; Synapsins: from synapse to network hyperexcitability and epilepsy. Semin Cell Dev Biol 2011,22(4),408-415","journal-title":"Semin Cell Dev Biol"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11064-014-1472-2","volume":"40","author":"Krishnakumar A.","year":"2015","unstructured":"Krishnakumar A.; Anju T.R.; Abraham P.M.; Paulose C.S.; Alteration in 5-HT-C, NMDA receptor and IP3 in cerebral cortex of epileptic rats: restorative role of Bacopa monnieri. Neurochem Res 2015,40(1),216-225","journal-title":"Neurochem Res"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1523\/ENEURO.0301-16.2017","volume":"4","author":"Hall A.M.","year":"2017","unstructured":"Hall A.M.; Brennan G.P.; Nguyen T.M.; Singh-Taylor A.; Mun H.S.; Sargious M.J.; Baram T.Z.; The role of Sirt1 in epileptogenesis. eNeuro 2017,4(1),4","journal-title":"eNeuro"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.brainresbull.2008.12.005","volume":"78","author":"Chindo B.A.","year":"2009","unstructured":"Chindo B.A.; Anuka J.A.; McNeil L.; Yaro A.H.; Adamu S.S.; Amos S.; Connelly W.K.; Lees G.; Gamaniel K.S.; Anticonvulsant properties of saponins from Ficus platyphylla stem bark. Brain Res Bull 2009,78(6),276-282","journal-title":"Brain Res Bull"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresrev.2006.09.006","volume":"54","author":"Galtrey C.M.","year":"2007","unstructured":"Galtrey C.M.; Fawcett J.W.; The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Brain Res Rev 2007,54(1),1-18","journal-title":"Brain Res Brain Res Rev"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/14737175.2016.1226135","volume":"16","author":"DeGiorgio C.M.","year":"2016","unstructured":"DeGiorgio C.M.; Taha A.Y.; Omega-3 fatty acids (\u1ff3-3 fatty acids) in epilepsy: animal models and human clinical trials. Expert Rev Neurother 2016,16(10),1141-1145","journal-title":"Expert Rev Neurother"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/glia.22317","volume":"60","author":"Binder D.K.","year":"2012","unstructured":"Binder D.K.; Nagelhus E.A.; Ottersen O.P.; Aquaporin-4 and epilepsy. Glia 2012,60(8),1203-1214","journal-title":"Glia"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.neuroscience.2004.08.053","volume":"129","author":"Nagelhus E.A.","year":"2004","unstructured":"Nagelhus E.A.; Mathiisen T.M.; Ottersen O.P.; Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 2004,129(4),905-913","journal-title":"Neuroscience"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1078\/0944-7113-00103","volume":"9","author":"Bienvenu E.","year":"2002","unstructured":"Bienvenu E.; Amabeoku G.J.; Eagles P.K.; Scott G.; Springfield E.P.; Anticonvulsant activity of aqueous extract of Leonotis leonurus. Phytomedicine 2002,9(3),217-223","journal-title":"Phytomedicine"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00018-009-0227-8","volume":"67","author":"Fornasiero E.F.","year":"2010","unstructured":"Fornasiero E.F.; Bonanomi D.; Benfenati F.; Valtorta F.; The role of synapsins in neuronal development. Cell Mol Life Sci 2010,67(9),1383-1396","journal-title":"Cell Mol Life Sci"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yebeh.2018.08.016","volume":"87","author":"Ibrahim F.A.S.","year":"2018","unstructured":"Ibrahim F.A.S.; Ghebremeskel K.; Abdel-Rahman M.E.; Ahmed A.A.M.; Mohmed I.M.; Osman G.; Elseed M.; Hamed A.; Rabinowicz A.L.; Salih M.A.M.; Elbashir M.I.; Daak A.A.; The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial. Epilepsy Behav 2018,87,32-38","journal-title":"Epilepsy Behav"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1074\/jbc.M112.399782","volume":"288","author":"Paonessa F.","year":"2013","unstructured":"Paonessa F.; Latifi S.; Scarongella H.; Cesca F.; Benfenati F.; Specificity protein 1 (Sp1)-dependent activation of the synapsin I gene (SYN1) is modulated by RE1-silencing transcription factor (REST) and 5\u2032-cytosine-phosphoguanine (CpG) methylation. J Biol Chem 2013,288(5),3227-3239","journal-title":"J Biol Chem"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/hmg\/ddt071","volume":"22","author":"Lignani G.","year":"2013","unstructured":"Lignani G.; Raimondi A.; Ferrea E.; Rocchi A.; Paonessa F.; Cesca F.; Orlando M.; Tkatch T.; Valtorta F.; Cossette P.; Baldelli P.; Benfenati F.; Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics and short-term plasticity. Hum Mol Genet 2013,22(11),2186-2199","journal-title":"Hum Mol Genet"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.celrep.2016.02.042","volume":"14","author":"Brennan G.P.","year":"2016","unstructured":"Brennan G.P.; Dey D.; Chen Y.; Patterson K.P.; Magnetta E.J.; Hall A.M.; Dube C.M.; Mei Y.T.; Baram T.Z.; Dual and opposing roles of microRNA-124 in epilepsy are mediated through inflammatory and NRSF-dependent gene networks. Cell Rep 2016,14(10),2402-2412","journal-title":"Cell Rep"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.yebeh.2013.06.014","volume":"28","author":"Ngoupaye G.T.","year":"2013","unstructured":"Ngoupaye G.T.; Ngo Bum E.; Ngah E.; Talla E.; Moto F.C.O.; Taiwe G.S.; Rakotonirina A.; Rakotonirina S.V.; The anticonvulsant and sedative effects of Gladiolus dalenii extracts in mice. Epilepsy Behav 2013,28(3),450-456","journal-title":"Epilepsy Behav"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejphar.2007.07.011","volume":"574","author":"Park H.G.","year":"2007","unstructured":"Park H.G.; Yoon S.Y.; Choi J.Y.; Lee G.S.; Choi J.H.; Shin C.Y.; Son K.H.; Lee Y.S.; Kim W.K.; Ryu J.H.; Ko K.H.; Cheong J.H.; Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur J Pharmacol 2007,574(2-3),112-119","journal-title":"Eur J Pharmacol"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S2095-4964(15)60161-3","volume":"13","author":"Sharma H.","year":"2015","unstructured":"Sharma H.; Garg M.; A review of traditional use, phytoconstituents and biological activities of Himalayan yew, Taxus wallichiana. J Integr Med 2015,13(2),80-90","journal-title":"J Integr Med"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11571-016-9420-2","volume":"11","author":"Tang H.","year":"2017","unstructured":"Tang H.; Shao C.; He J.; Down-regulated expression of aquaporin-4 in the cerebellum after status epilepticus. Cogn Neurodyn 2017,11(2),183-188","journal-title":"Cogn Neurodyn"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresbull.2005.10.010","volume":"69","author":"Mahomed I.M.","year":"2006","unstructured":"Mahomed I.M.; Ojewole J.A.; Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceae] secondary root aqueous extract in mice. Brain Res Bull 2006,69(1),57-62","journal-title":"Brain Res Bull"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"1759091415605486","DOI":"10.1177\/1759091415605486","volume":"7","author":"Hubbard J.A.","year":"2015","unstructured":"Hubbard J.A.; Hsu M.S.; Seldin M.M.; Binder D.K.; Expression of the astrocyte water channel aquaporin-4 in the mouse brain. ASN Neuro 2015,7(5),1759091415605486","journal-title":"ASN Neuro"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/ijms18071599","volume":"18","author":"Su J.","year":"2017","unstructured":"Su J.; Liu J.; Yan X.Y.; Zhang Y.; Zhang J.J.; Zhang L.C.; Sun L.K.; Cytoprotective effect of the UCP2-SIRT3 signaling pathway by decreasing mitochondrial oxidative stress on cerebral ischemia\u2013reperfusion injury. Int J Mol Sci 2017,18(7),1599","journal-title":"Int J Mol Sci"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"172801","DOI":"10.1155\/2015\/172801","volume":"2015","author":"Thomas J.","year":"2015","unstructured":"Thomas J.; Thomas C.J.; Radcliffe J.; Itsiopoulos C.; Omega-3 fatty acids in early prevention of inflammatory neurodegenerative disease: a focus on Alzheimer\u2019s disease. BioMed Res Int 2015,2015,172801","journal-title":"BioMed Res Int"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.brainresbull.2017.02.011","volume":"136","author":"Hubbard J.A.","year":"2018","unstructured":"Hubbard J.A.; Szu J.I.; Binder D.K.; The role of aquaporin-4 in synaptic plasticity, memory and disease. Brain Res Bull 2018,136,118-129","journal-title":"Brain Res Bull"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainresbull.2007.08.002","volume":"75","author":"Ojewole J.A.","year":"2008","unstructured":"Ojewole J.A.; Anticonvulsant property of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract. Brain Res Bull 2008,75(1),126-132","journal-title":"Brain Res Bull"},{"key":"ref=326","author":"Mathew J.","year":"2012","unstructured":"Mathew J.; Balakrishnan S.; Antony S.; Abraham P. M.; Paulose C. S.; Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A J Biom Sci 2012","journal-title":"J Biom Sci"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jep.2015.06.039","volume":"172","author":"Garba K.","year":"2015","unstructured":"Garba K.; Yaro A.H.; Ya\u2019u J.; Anticonvulsant effects of ethanol stem bark extract of Lannea barteri (Anacardiaceae) in mice and chicks. J Ethnopharmacol 2015,172,227-231","journal-title":"J Ethnopharmacol"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"e0212138","DOI":"10.1371\/journal.pone.0212138","volume":"14","author":"Hu L.","year":"2019","unstructured":"Hu L.; Zhang S.; Wen H.; Liu T.; Cai J.; Du D.; Zhu D.; Chen F.; Xia C.; Melatonin decreases M1 polarization via attenuating mitochondrial oxidative damage depending on UCP2 pathway in prorenin-treated microglia. PLoS One 2019,14(2),e0212138","journal-title":"PLoS One"},{"key":"ref=329","first-page":"209","volume":"3","author":"Ahmad M.","year":"2015","unstructured":"Ahmad M.; Yaseen M.; Bhat A.; Ganai B.A.; Zargar M.A.; Ganie S.A.; Qureshi R.; Taxus wallichiana as a Potential in vitro antioxidant with good lethal effect on pathogenic bactarial strains. Am J Phytomed Clin Ther 2015,3(3),209-221","journal-title":"Am J Phytomed Clin Ther"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuro.2018.07.006","volume":"68","author":"Nagib M.M.","year":"2018","unstructured":"Nagib M.M.; Tadros M.G.; Al-Khalek H.A.A.; Rahmo R.M.; Sabri N.A.; Khalifa A.E.; Masoud S.I.; Molecular mechanisms of neuroprotective effect of adjuvant therapy with phenytoin in pentylenetetrazole-induced seizures: Impact on Sirt1\/NRF2 signaling pathways. Neurotoxicology 2018,68,47-65","journal-title":"Neurotoxicology"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jep.2007.12.021","volume":"116","author":"Nisar M.","year":"2008","unstructured":"Nisar M.; Khan I.; Simjee S.U.; Gilani A.H.; Obaidullah ; Perveen H.; Anticonvulsant, analgesic and antipyretic activities of Taxus wallichiana Zucc. J Ethnopharmacol 2008,116(3),490-494","journal-title":"J Ethnopharmacol"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.eplepsyres.2011.09.006","volume":"98","author":"Pahuja M.","year":"2012","unstructured":"Pahuja M.; Mehla J.; Reeta K.H.; Joshi S.; Gupta Y.K.; Root extract of Anacyclus pyrethrum ameliorates seizures, seizure-induced oxidative stress and cognitive impairment in experimental animals. Epilepsy Res 2012,98(2-3),157-165","journal-title":"Epilepsy Res"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/ptr.1072","volume":"17","author":"Raza M.","year":"2003","unstructured":"Raza M.; Shaheen F.; Choudhary M.I.; Rahman A.U.; Sombati S.; Suria A.; Rafiq A.; DeLorenzo R.J.; Anticonvulsant effect of FS-1 subfraction isolated from roots of Delphinim denudatum on hippocampal pyramidal neurons. Phytother Res 2003,17(1),38-43","journal-title":"Phytother Res"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1078\/0944-7113-00113","volume":"9","author":"Sayyah M.","year":"2002","unstructured":"Sayyah M.; Valizadeh J.; Kamalinejad M.; Anticonvulsant activity of the leaf essential oil of Laurus nobilis against pentylenetetrazole- and maximal electroshock-induced seizures. Phytomedicine 2002,9(3),212-216","journal-title":"Phytomedicine"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.expneurol.2015.07.009","volume":"274","author":"Yutsudo N.","year":"2015","unstructured":"Yutsudo N.; Kitagawa H.; Involvement of chondroitin 6-sulfation in temporal lobe epilepsy. Exp Neurol 2015,274(Pt B),126-133","journal-title":"Exp Neurol"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fncel.2013.00138","volume":"7","author":"Toader O.","year":"2013","unstructured":"Toader O.; Forte N.; Orlando M.; Ferrea E.; Raimondi A.; Baldelli P.; Benfenati F.; Medrihan L.; Dentate gyrus network dysfunctions precede the symptomatic phase in a genetic mouse model of seizures. Front Cell Neurosci 2013,7,138","journal-title":"Front Cell Neurosci"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/epi.12034","volume":"53","author":"Casillas-Espinosa P.M.","year":"2012","unstructured":"Casillas-Espinosa P.M.; Powell K.L.; O\u2019Brien T.J.; Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy. Epilepsia 2012,53(Suppl. 9),41-58","journal-title":"Epilepsia"},{"key":"ref=338","first-page":"387","volume":"66","author":"Miao Q.L.","year":"2014","unstructured":"Miao Q.L.; Ye Q.; Zhang X.H.; Perineuronal net, CSPG receptor and their regulation of neural plasticity. Sheng Li Xue Bao 2014,66(4),387-397","journal-title":"Sheng Li Xue Bao"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"18760","DOI":"10.18632\/oncotarget.24655","volume":"9","author":"Barbieri R.","year":"2018","unstructured":"Barbieri R.; Contestabile A.; Ciardo M.G.; Forte N.; Marte A.; Baldelli P.; Benfenati F.; Onofri F.; Synapsin I and Synapsin II regulate neurogenesis in the dentate gyrus of adult mice. Oncotarget 2018,9(27),18760-18774","journal-title":"Oncotarget"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.freeradbiomed.2011.06.022","volume":"51","author":"Mailloux R.J.","year":"2011","unstructured":"Mailloux R.J.; Harper M.E.; Uncoupling proteins and the control of mitochondrial reactive oxygen species production. Free Radic Biol Med 2011,51(6),1106-1115","journal-title":"Free Radic Biol Med"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jep.2017.12.008","volume":"215","author":"Kumar R.","year":"2018","unstructured":"Kumar R.; Arora R.; Agarwal A.; Gupta Y.K.; Protective effect of Terminalia chebula against seizures, seizure-induced cognitive impairment and oxidative stress in experimental models of seizures in rats. J Ethnopharmacol 2018,215,124-131","journal-title":"J Ethnopharmacol"},{"key":"ref=342","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2019.4188","volume":"44","author":"Zhao R.Z.","year":"2019","unstructured":"Zhao R.Z.; Jiang S.; Zhang L.; Yu Z.B.; Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med 2019,44(1),3-15","journal-title":"Int J Mol Med"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","volume":"17","author":"Nielsen S.","year":"1997","unstructured":"Nielsen S.; Nagelhus E.A.; Amiry-Moghaddam M.; Bourque C.; Agre P.; Ottersen O.P.; Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997,17(1),171-180","journal-title":"J Neurosci"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2174\/1568026616666160204123107","volume":"16","author":"Tejada S.","year":"2016","unstructured":"Tejada S.; Martorell M.; Cap\u00f3 X.; Tur J.A.; Pons A.; Sureda A.; J.; Pons, A.; Sureda, A. Omega-3 fatty acids in the management of epilepsy. Curr Top Med Chem 2016,16(17),1897-1905","journal-title":"Curr Top Med Chem"},{"key":"ref=345","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neuroscience.2013.08.050","volume":"253","author":"Soleman S.","year":"2013","unstructured":"Soleman S.; Filippov M.A.; Dityatev A.; Fawcett J.W.; Targeting the neural extracellular matrix in neurological disorders. Neuroscience 2013,253,194-213","journal-title":"Neuroscience"},{"key":"ref=346","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.yebeh.2013.01.007","volume":"27","author":"Soman S.","year":"2013","unstructured":"Soman S.; Anju T.R.; Jayanarayanan S.; Antony S.; Paulose C.S.; Impaired motor learning attributed to altered AMPA receptor function in the cerebellum of rats with temporal lobe epilepsy: ameliorating effects of Withania somnifera and withanolide A. Epilepsy Behav 2013,27(3),484-491","journal-title":"Epilepsy Behav"},{"key":"ref=347","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-06630-0","volume":"7","author":"Ishihara Y.","year":"2017","unstructured":"Ishihara Y.; Itoh K.; Tanaka M.; Tsuji M.; Kawamoto T.; Kawato S.; Yamazaki T.; Potentiation of 17\u03b2-estradiol synthesis in the brain and elongation of seizure latency through dietary supplementation with docosahexaenoic acid. Sci Rep 2017,7,1-11","journal-title":"Sci Rep"},{"key":"ref=348","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1007\/s12035-015-9224-0","volume":"53","author":"Tan Y.","year":"2016","unstructured":"Tan Y.; Ren H.; Shi Z.; Yao X.; He C.; Kang J.X.; Wan J.B.; Li P.; Yuan T.F.; Su H.; Endogenous docosahexaenoic acid (dha) prevents a\u03b21\u201342 oligomer-induced neuronal injury. Mol Neurobiol 2016,53(5),3146-3153","journal-title":"Mol Neurobiol"},{"key":"ref=349","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.intimp.2019.03.043","volume":"71","author":"Ding Y.","year":"2019","unstructured":"Ding Y.; Zheng Y.; Huang J.; Peng W.; Chen X.; Kang X.; Zeng Q.; UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury. Int Immunopharmacol 2019,71,336-349","journal-title":"Int Immunopharmacol"},{"key":"ref=350","doi-asserted-by":"publisher","first-page":"808","DOI":"10.14336\/AD.2017.1115","volume":"9","author":"Teng Z.","year":"2018","unstructured":"Teng Z.; Wang A.; Wang P.; Wang R.; Wang W.; Han H.; The effect of aquaporin-4 knockout on interstitial fluid flow and the structure of the extracellular space in the deep brain. Aging Dis 2018,9(5),808-816","journal-title":"Aging Dis"},{"key":"ref=351","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/dvdy.24582","volume":"247","author":"Tiwari D.","year":"2018","unstructured":"Tiwari D.; Peariso K.; Gross C.; MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application. Dev Dyn 2018,247(1),94-110","journal-title":"Dev Dyn"},{"key":"ref=352","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.omtn.2016.11.002","volume":"6","author":"Reschke C.R.","year":"2017","unstructured":"Reschke C.R.; Silva L.F.A.; Norwood B.A.; Senthilkumar K.; Morris G.; Sanz-Rodriguez A.; Conroy R.M.; Costard L.; Neubert V.; Bauer S.; Farrell M.A.; O\u2019Brien D.F.; Delanty N.; Schorge S.; Pasterkamp R.J.; Rosenow F.; Henshall D.C.; Potent anti-seizure effects of locked nucleic acid antagomirs targeting miR-134 in multiple mouse and rat models of epilepsy. Mol Ther Nucleic Acids 2017,6,45-56","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=353","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1073858417705840","volume":"24","author":"Hauser R.M.","year":"2018","unstructured":"Hauser R.M.; Henshall D.C.; Lubin F.D.; The epigenetics of epilepsy and its progression. Neuroscientist 2018,24(2),186-200","journal-title":"Neuroscientist"},{"key":"ref=354","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3233\/BPL-160036","volume":"3","author":"Bielefeld P.","year":"2017","unstructured":"Bielefeld P.; Mooney C.; Henshall D.C.; Fitzsimons C.P.; miRNA-mediated regulation of adult hippocampal neurogenesis; implications for epilepsy. Brain Plast 2017,3(1),43-59","journal-title":"Brain Plast"},{"key":"ref=355","first-page":"37","volume":"16","author":"Ma Y.","year":"2018","unstructured":"Ma Y.; The challenge of microRNA as a biomarker of epilepsy. Curr Neuropharmacol 2018,16(1),37-42","journal-title":"Curr Neuropharmacol"},{"key":"ref=356","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ebiom.2019.07.008","volume":"45","author":"Morris G.","year":"2019","unstructured":"Morris G.; Reschke C.R.; Henshall D.C.; Targeting microRNA-134 for seizure control and disease modification in epilepsy. EBioMedicine 2019,45,646-654","journal-title":"EBioMedicine"},{"key":"ref=357","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fphar.2017.00770","volume":"8","author":"Qian Y.","year":"2017","unstructured":"Qian Y.; Song J.; Ouyang Y.; Han Q.; Chen W.; Zhao X.; Xie Y.; Chen Y.; Yuan W.; Fan C.; Advances in roles of miR-132 in the nervous system. Front Pharmacol 2017,8,770","journal-title":"Front Pharmacol"},{"key":"ref=358","volume":"11","author":"Li T. R.","year":"2018","unstructured":"Li T. R.; Jia Y. J.; Ma C.; Qiu W. Y.; Wang Q.; Shao X. Q.; Lv R. J.; The role of the microRNA-146a\/complement factor H\/interleukin-1\u03b2-mediated inflammatory loop circuit in the perpetuate inflammation of chronic temporal lobe epilepsy Dise Model Mech 2018,11","journal-title":"Dise Model Mech"},{"key":"ref=359","doi-asserted-by":"publisher","first-page":"104508","DOI":"10.1016\/j.nbd.2019.104508","volume":"130","author":"Tiwari D.","year":"2019","unstructured":"Tiwari D.; Brager D.H.; Rymer J.K.; Bunk A.T.; White A.R.; Elsayed N.A.; Krzeski J.C.; Snider A.; Schroeder Carter L.M.; Danzer S.C.; Gross C.; MicroRNA inhibition upregulates hippocampal A-type potassium current and reduces seizure frequency in a mouse model of epilepsy. Neurobiol Dis 2019,130,104508","journal-title":"Neurobiol Dis"},{"key":"ref=360","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3892\/ijmm.2018.3711","volume":"42","author":"Duan W.","year":"2018","unstructured":"Duan W.; Chen Y.; Wang X.R.; MicroRNA\u2011155 contributes to the occurrence of epilepsy through the PI3K\/Akt\/mTOR signaling pathway. Int J Mol Med 2018,42(3),1577-1584","journal-title":"Int J Mol Med"},{"key":"ref=361","doi-asserted-by":"publisher","first-page":"33943","DOI":"10.1038\/srep33943","volume":"6","author":"Danis B.","year":"2016","unstructured":"Danis B.; van Rikxoort M.; Kretschmann A.; Zhang J.; Godard P.; Andonovic L.; Siegel F.; Niehusmann P.; Hanon E.; Delev D.; von Lehe M.; Kaminski R.M.; Pfeifer A.; Foerch P.; Differential expression of miR-184 in temporal lobe epilepsy patients with and without hippocampal sclerosis - Influence on microglial function. Sci Rep 2016,6,33943","journal-title":"Sci Rep"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/185835","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/185835\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/185835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T04:28:29Z","timestamp":1638678509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/185835\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":361,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,1,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527319666200910153827","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}